DeKalb County, Ga., funds by Health and Human Services, Department of

Listing $194,649,298.02 in stimulus funds from Health and Human Services, Department of for DeKalb

Note: For some programs where states do not report where money will be distributed across the state, we do not have the allocation for individual counties. Those programs include: Medicaid, unemployment benefits and food stamps. Those amounts are included in the totals for where the state agency receiving that money is located.

Amount refers to both the amount of stimulus funding going toward the project and the face value of the loan.

Recipient	Amount	Description	Federal Dept./Agency	Date
EMORY UNIVERSITY	$14,868,223	National Center for Research Resources, Recovery Act Construction Support The goal of this project is the construction of a new dual function 19,800 sq ft building devoted to NHP research in two of the most rapidly growing areas of the Yerkes research portfolio that align with national health prioritities -infectious disease and ... Show more See details	National Institutes of Health	3/25/2010
ICF MACRO, INC	$12,564,692	ICF Macro was awarded a contract to develop a Training and Technical Assistance Resource Center to support CPPW grantees and provide on-going access to information on expert policy, system and environmental change, field technical assistance, training too This spending item is part of a $13,958,455 allocation. See details	Centers for Disease Control and Prevention	4/26/2010
MERLIN INTERNATIONAL, INC.	$7,913,432	DHHS CSIRC Security Incident and Event Management See details	Centers for Disease Control and Prevention	3/31/2010
MERLIN INTERNATIONAL, INC.	$5,063,856	Network Forensics and Analytics See details	Centers for Disease Control and Prevention	3/10/2010
EMORY UNIVERSITY	$4,167,520	Trans-NIH Recovery Act Research Support The purpose of this award of American Recovery and Reinvestment Act (ARRA) funds is to accelerate the tempo of scientific research at the Emory HIV/AIDS Clinical Trials Unit (EHCTU). The ARRA funds are requested specifically to accelerate the research bei This spending item is part of a $4,827,520 allocation. See details	National Institutes of Health	9/01/2009
SCIMETRIKA, LLC	$3,397,277	The purpose and objective of this task order is to obtain and maintain scientific management, operations, data analysis, and communications support services critical to the mission of the Radiation Studies Branch (RBS) within the Centers for Disease Contr See details	Centers for Disease Control and Prevention	5/24/2011
PARTNERSHIP FOR COMMUNITY ACTION, INC.	$3,262,250	ARRA - Early Head Start This award provides for ARRA Early Head Start Expansion funded to serve 120 infants, toddlers, and pregnant women. 32 slots will be used for home based services. The remaining 88 will be served in a center based option. The Early Head Start Expansion will See details	Administration for Children and Families	11/23/2009
DEKALB, COUNTY OF	$3,196,347	ARRA - Prevention and Wellness--Communities Putting Prevention to Work The DeKalb County Initiative aims to create a healthier, tobacco-free community by implementing evidence-based intervention strategies to increase awareness of the health consequences of tobacco use, decrease exposure to secondhanand smoke, increase efforts... Show more See details	Centers for Disease Control and Prevention	3/18/2010
EASTER SEALS NORTH GEORGIA, INC.	$3,188,873	ARRA - Early Head Start Easter Seals North Georgia Early Head Start Expansion grant serving 120 children ages 0-3 years. This is a full-day, full-year program operating in Fulton, Jackson, Madison and Oconee counties Georgia. The Early Head Start program provides family-center See details	Administration for Children and Families	11/23/2009
EMORY UNIVERSITY	$3,148,467	Trans-NIH Recovery Act Research Support Epigenetic Marks as Peripheral Biomarkers of Autism Autism spectrum disorders (ASD) are a common phenotype with a complex etiology. While a rare single gene or genomic interval may be sufficient to lead to ASD, most patients likely owe their disease to a See details	National Institutes of Health	9/28/2009
PARTNERSHIP FOR COMMUNITY ACTION, INC.	$3,040,971	ARRA - Community Services Block Grant ARRA Supplemental Funding for the Community Services Block Grant (CSBG) Program: The CSBG ARRA grant was primarily used to prevent homelessness and provide employment and employment supports. This spending item is part of a $26,896,180 allocation. See details	Administration for Children and Families	4/10/2009
AFFIGENT, LLC	$3,008,810	Procure and supply multiple items of ADP components. See details	Centers for Disease Control and Prevention	7/15/2010
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION	$3,001,547	In support of the Public Health Laboratory Interoperability Solutions and Solution Architecture (PHLISSA) Task Order, SAIC will support the development of standards-based architectures to continue the significant progress toward full interoperability amon This spending item is part of a $3,672,289 allocation. See details	Centers for Disease Control and Prevention	7/09/2010
MERLIN INTERNATIONAL, INC.	$2,441,765	Incident Prevention and Incident Detection system. See details	Centers for Disease Control and Prevention	3/10/2010
EMORY UNIVERSITY	$2,373,533	Trans-NIH Recovery Act Research Support Phase II study: Mobilization of progenitor cells in peripheral arterial disease Atherosclerotic peripheral arterial disease (PAD) of the ileo-femoral circulation is a common condition that afflicts up to 5% of the U.S. population, often resulting in seve See details	National Institutes of Health	9/28/2009
NORTHROP GRUMMAN INFORMATION TECHNOLOGY INC	$2,244,128	With the award of this contract the Centers for Disease Control and Prevention (CDC) seeks to obtain technical, operational and product support to Health Information Technology for Economic and Clinical Health (HITECH) Act grantees for the Immunization In See details	Centers for Disease Control and Prevention	9/08/2010
EMORY UNIVERSITY	$2,202,768	Trans-NIH Recovery Act Research Support Transplantation is the preferred method of treatment for many forms of end-stage organ failure. Current therapy in clinical transplantation relies on potent non-specific immunosuppressive drugs to inhibit rejection. While short-term results have improved See details	National Institutes of Health	7/22/2009
CNI INFORMATION TECHNOLOGY, LLC	$2,171,559	Cyber Security Support for DHHS / CDC / Cyber Security Support (THIS REPORT REFLECTS THE CUMMULATIVE INVOICED TOTALS SINCE THE START OF PERFORMANCE ON THE TASK) See details	Centers for Disease Control and Prevention	2/01/2010
EMORY UNIVERSITY	$2,088,410	Trans-NIH Recovery Act Research Support Vaccine Induced Immunity in the Young and Aged: The novel H1N1 influenza virus caused a pandemic that clearly demonstrated the global health threat of reassortant influenza strains. This newly emergent strain is immunologically distinct from other influen This spending item is part of a $2,462,810 allocation. See details	National Institutes of Health	9/21/2009
PARTNERSHIP FOR COMMUNITY ACTION, INC.	$2,039,774	ARRA - Head Start This award provides ARRA Head Start Expansion to serve 160 preschool age children in DeKalb and Rockdale Counties in the center based option. The purpose of the Head Start program is to promote school readiness of low-income children through the provision See details	Administration for Children and Families	9/18/2009
NORTHROP GRUMMAN INFORMATION TECHNOLOGY INC	$1,971,837	With the award of this contract the Centers for Disease Control and Prevention (CDC) seeks to provide technical, operational, and product support to assist the Immunization Information System Support Branch (IISSB) with development of ACIP-approved, clin See details	Centers for Disease Control and Prevention	9/20/2010
EMORY UNIVERSITY	$1,942,085	Trans-NIH Recovery Act Research Support A major challenge in vaccinology is that the efficacy of a vaccine can only be ascertained retrospectively, upon infection. The identification of molecular signatures induced rapidly after vaccination, which correlate with and predict, the later developme This spending item is part of a $3,213,142 allocation. See details	National Institutes of Health	7/12/2010
CNI INFORMATION TECHNOLOGY, LLC	$1,849,743	Computer Security Incident Response Center (CSIRC) - Monitors threats and incidents for DHHS and its Operational Divisions. This includes 24x7x365 Security Operations Center, Forensics support, Security Systems Engineering (hardware & software), and Proje See details	Centers for Disease Control and Prevention	12/21/2009
MERLIN INTERNATIONAL, INC.	$1,571,991	Arcsight Product, Maintenance, and Installation and Traing Services. See details	Centers for Disease Control and Prevention	8/05/2010
EMORY UNIVERSITY	$1,535,966	The Chemical Biology Consortium (CBC) will identify a cadre of members with the biological expertise and capability to rapidly develop sufficient information both in vitro and in vivo to determine the potential of novel discoveries, from the Cancer Genome This spending item is part of a $5,000,000 allocation. See details	National Institutes of Health	12/22/2009
EMORY UNIVERSITY	$1,445,834	Trans-NIH Recovery Act Research Support Many studies have suggested a relationship between depression and cardiovascular disease (CVD), but its causal role in the etiology of CVD is still debated and the mechanisms are unclear. Rather than being causally related, depression and CVD could share This spending item is part of a $1,544,566 allocation. See details	National Institutes of Health	8/17/2009
GEORGIA ASSOCIATION FOR PRIMARY HEALTH CARE, INC	$1,400,000	ARRA Health Center Integrated Services Development Initiative[g1] Electronic Health Record Implementation for Health Center Controlled Networks ? HRSA -09-198 Georgia HCCN HIT Expansion ? Atlanta Urban FQHC EHR & HIE H2LIT16823 Oakhurst Medical Centers, Inc., Southside Healthcare, Inc., and West EnEnd Medical Centers, I... Show more See details	Health Resources and Services Administration	9/19/2009
EMORY UNIVERSITY	$1,385,000	Trans-NIH Recovery Act Research Support Faculty Recruitment in Novel Therapeutic Strategies for Neurodegenerative Disease. This proposal seeks support for new faculty recruitment to enhance research capacity at Emory University in the area of novel therapeutic strategies for neurodegenerative d See details	National Institutes of Health	9/25/2009
EMORY UNIVERSITY	$1,322,626	ARRA Grants for Training in Primary Care Medicine and Dentistry Training and Enhancement Training in Primary Care Medicine and Dentistry: Residency Training in Primary Care The General Internal Medicine/Primary Care (GIM/PC) Residency Program, prepares generalist physicians to provide high quality, c cost effective health care, while focusing o... Show more See details	Health Resources and Services Administration	9/03/2010
EMORY UNIVERSITY	$1,284,750	Trans-NIH Recovery Act Research Support Transplantation is the ideal therapy for end stage heart and end stage kidney failure, but allograft survival and function remain suboptimal. This CTOT renewal application will build upon the findings resulting from the previous 4 years of studying biomar This spending item is part of a $9,955,156 allocation. See details	National Institutes of Health	9/13/2010
EMORY UNIVERSITY	$1,280,745	Trans-NIH Recovery Act Research Support The overall goal of our current U19 grant is to understand how a successful vaccine, the live yellow fever virus (YFV-17D) vaccine, induces long-term immunological memory and protective immunity in humans. The YFV-17D vaccine is recommended by the Centers See details	National Institutes of Health	9/01/2009
EMORY UNIVERSITY	$1,246,164	Trans-NIH Recovery Act Research Support 'FMRP-mediated translation regulation in neuronal development ' The fragile X mental retardation protein (FMRP) binds mRNA and microRNA, is associated with polyribosomes, and is localized in dendrites and axons. Hence, FMRP is thought t See details	National Institutes of Health	7/13/2009
EMORY UNIVERSITY	$1,194,287	Trans-NIH Recovery Act Research Support Nanotechnology for Multiplexed and Intraoperative Cancer Detection; This grant application aims to develop new and innovative technologies for applications in cancer surgery. The main goals are to help the surgeon to delineate tumor margins, to identify This spending item is part of a $1,998,560 allocation. See details	National Institutes of Health	9/30/2009
BANYAN COMMUNICATIONS, INC.	$1,145,352	Banyan Communications has been contracted by the Centers for Disease Control and Prevention (CDC) to support the Communities Putting Prevention to Work (CPPW) initiative. The goal of the CPPW initiative is to reduce risk factors, prevent or delay chroni This spending item is part of a $2,119,980 allocation. See details	Centers for Disease Control and Prevention	8/26/2010
BATTELLE MEMORIAL INSTITUTE	$1,114,298	The purpose of this Task Order is to conduct an evaluation of the effectiveness of the various dissemination and implementation approaches undertaken by the Office of Communications and Knowledge Transfer (OCKT) related to AHRQG??s comparative effectivene This spending item is part of a $2,371,179 allocation. See details	Agency for Healthcare Research and Quality	9/15/2010
BLAZESPORTS AMERICA, INC.	$1,112,010	ARRA - Prevention and Wellness - Leveraging National Organizations 2010 ARRA Preventiona and Wellness - Leveraging National Organizations See details	Health and Human Services, Department of	8/27/2010
SCIMETRIKA, LLC	$1,108,469	The This task order request is composed of four (4) individual tasks. This task order request will have four (4) individual descriptions for this section of the RFTOP. Task 1: The purpose of this task order is to obtain technical assistance and operatio See details	Centers for Disease Control and Prevention	9/23/2009
EMORY UNIVERSITY	$1,100,237	Trans-NIH Recovery Act Research Support Systems and Computational Neuroscience at Emory University We seek to foster and enhance Systems and Computational Neuroscience at Emory University by hiring a new assistant professor with primary appointment in the Department of Biology and adjunct appoi This spending item is part of a $1,192,500 allocation. See details	National Institutes of Health	9/25/2009
EMORY UNIVERSITY	$1,091,593	Trans-NIH Recovery Act Research Support Title: CNV Atlas of Human Development Abstract: The recent discovery that copy number variations (CNVs), the loss or gain of small genomic segments, is common in all normal individuals and plays a major role in human phenotypic variation and disease, has This spending item is part of a $3,423,980 allocation. See details	National Institutes of Health	9/29/2009
EMORY UNIVERSITY	$1,009,880	Trans-NIH Recovery Act Research Support It is the primary objective of this program to elucidate correlates of immune-mediated protection against HIV-1 infection using pre-clinical animal models. To this end, Project 1 will determine humoral and cell-mediated immune responses to an attenuated S This spending item is part of a $5,581,859 allocation. See details	National Institutes of Health	9/01/2009
EMORY UNIVERSITY	$1,000,000	Trans-NIH Recovery Act Research Support New Frontiers in OMPD: Stem Cell Theory of Oculopharyngeal Muscular Dystrophy The Challenge: Oculopharyngeal muscular dystrophy (OPMD) is a rare autosomal dominant disease of late onset for which no cure exists. It is characterized by eyelid drooping, d See details	National Institutes of Health	9/25/2009
EMORY UNIVERSITY	$1,000,000	Trans-NIH Recovery Act Research Support Award Title: Comprehensive mutation detection for Neuromuscular disorders: Bringing new technologies to clinic Purpose:We propose to design a set of microarray-based tools that will enable the high- throughput comprehensive identification of genetic varia See details	National Institutes of Health	9/25/2009
EMORY UNIVERSITY	$1,000,000	Trans-NIH Recovery Act Research Support Establishment of atransgenic monkey model of Huntington's disease This study is propose to monitor the gene expression and miRNA expression profile of the peripheral blood of these HD monkeys at six months intervals throughout the two budgeted years. Whi See details	National Institutes of Health	9/29/2009
EMORY UNIVERSITY	$1,000,000	Trans-NIH Recovery Act Research Support Project Summary (Abstract) This application addresses broad Challenge Area (14) Stem Cells, and meets a few specific Challenge Topics: 14-EB-101: Synthetic Delivery Systems for Generating Pluripotent Stem Cells 14-DK-101: Induced pluripotent stem cells G? See details	National Institutes of Health	3/23/2010
EMORY UNIVERSITY	$999,190	Trans-NIH Recovery Act Research Support WHO estimates that there are currently more than 30 million people living with HIV/AIDS and there is a great need to develop a safe and effective therapy that requires short-term intervention and long-term control of viral replication. The overall goal of See details	National Institutes of Health	9/28/2009
EMORY UNIVERSITY	$998,982	Trans-NIH Recovery Act Research Support Men who have sex with men (MSM) are the most heavily impacted risk group in the US HIV epidemic, both in absolute numbers and in infection rates. Within the US MSM HIV epidemic, black and Hispanic MSM are disproportionately affected compared to other raci See details	National Institutes of Health	9/24/2009
EMORY UNIVERSITY	$998,826	Trans-NIH Recovery Act Research Support Atlanta Clinical and Translation Science Institute (UL1): Supplement to the Translational Technologies and Resources Program to Advance Innovation through Imaging The Translational Technologies and Resources (TTR) Program of the Atlanta Clinical and Tran See details	National Institutes of Health	9/05/2009
EMORY UNIVERSITY	$982,444	Trans-NIH Recovery Act Research Support Epigenetic Biomarkers of Early Psychotropic Medication Exposure The use of antipsychotics, antidepressants, and anti-epileptics in both pre-pubertal and post-pubertal windows of brain development raise concerns about the functional effects of psychotrop See details	National Institutes of Health	9/25/2009
EMORY UNIVERSITY	$967,294	Trans-NIH Recovery Act Research Support Inhibitory antibodies to factor VIII develop in approximately 30% of patients with severe and moderately severe hemophilia A in response to infusions of factor VIII. Inhibitor development is associated with a lower quality of life and an increased economi See details	National Institutes of Health	9/11/2009
EMORY UNIVERSITY	$966,462	Trans-NIH Recovery Act Research Support In recent years, reactive oxygen species (ROS) have been shown to have critical roles in normal vascular function and the pathogenesis of vascular disease. These molecules have profound effects on vascular smooth muscle cell (VSMC) growth, migration and See details	National Institutes of Health	8/31/2009
EMORY UNIVERSITY	$965,006	Trans-NIH Recovery Act Research Support Streptococcus pyogenes, the group A streptococcus (GAS) is an important human pathogen that causes many types of disease, ranging in severity from strep throat to severe invasive disease and streptococcal toxic shock syndrome. By elucidating the regulatio See details	National Institutes of Health	5/22/2009
EMORY UNIVERSITY	$947,179	Trans-NIH Recovery Act Research Support Current theories of drug abuse view addiction as a disease, but inevitably, the element of volitional choice will remain one of the key components of the illness. The issue boils down to this: why does an individual choose to use drugs even when they kn See details	National Institutes of Health	6/05/2009
EMORY UNIVERSITY	$940,333	Trans-NIH Recovery Act Research Support In Crisis Intervention Team (CIT) training, police officers participate in 40 hours of specialized training provided by local mental health professionals, family members/advocates, and mental health consumer groups. Upon completion, these officers serve a See details	National Institutes of Health	9/30/2009
EMORY UNIVERSITY	$905,860	Trans-NIH Recovery Act Research Support Increasingly available and inexpensive high-throughput DNA sequencing holds great promise for biomedical research, but informatics challenge block the full realization of the potential of this transformative technology. In particular progress is limited b This spending item is part of a $1,515,743 allocation. See details	National Institutes of Health	9/24/2009
EMORY UNIVERSITY	$852,500	Trans-NIH Recovery Act Research Support Characterization of the Transcriptome in an Emerging Model for Social Behavior This application addresses broad Challenge Area (01): Behavior, Behavioral Change, and Prevention and specific Challenge Topic, 01-GM-102: Model organisms for social behavior s See details	National Institutes of Health	9/28/2009
EMORY UNIVERSITY	$850,172	Trans-NIH Recovery Act Research Support The scope of the CTOTC-02 collaborative encompasses unique barriers to successful kidney transplantation in children. Over the past forty years, the use of increasingly potent immunosuppressive drugs has lessened the risk for acute rejection (AR) and subs This spending item is part of a $1,649,526 allocation. See details	National Institutes of Health	8/01/2009
EMORY UNIVERSITY	$844,480	Trans-NIH Recovery Act Research Support The Yerkes National Primate Research Center (YNPRC) is one of the 8 NPRCs funded by a P51 grant from the NIH and NCRR to conduct basic and applied biomedical research using nonhuman primate (NHP) models to identify solutions for human health and societal See details	National Institutes of Health	9/26/2009
EMORY UNIVERSITY	$827,914	Recovery Act Comparative Effectiveness Research - AHRQ Prostate cancer is the most common solid tumor and the second leading cause of cancer death among American men. While surgery, radiation and observation have all been deemed appropriate for newly diagnosed men, tremendous uncertainty remains regagarding the... Show more This spending item is part of a $7,572,695 allocation. See details	Agency for Healthcare Research and Quality	8/12/2010
EMORY UNIVERSITY	$809,920	Trans-NIH Recovery Act Research Support Function of the Gamma HV68 M2 Antigen This is a revised competing renewal of an R01 grant to characterize the function of the murine gammaherpesvirus 68 (MHV68) M2 antigen. Gamma-herpesviruses are associated with the development of lymphoproliferative d See details	National Institutes of Health	7/28/2009
EMORY UNIVERSITY	$804,807	Trans-NIH Recovery Act Research Support POLARITY OF REDOX CONTROL AND RISK OF INJURY IN THE ALVEOLAR EPITHELIUM There is a significant difference in the concentrations and redox potentials between the fluid lining the epithelial surface and plasma for reduced and oxidized components of the an See details	National Institutes of Health	8/31/2009
EMORY UNIVERSITY	$797,069	Trans-NIH Recovery Act Research Support This application addresses broad Challenge Area (01) Behavior, Behavioral Change, and Prevention and specific Challenge Topic 03-MH-101* Biomarkers in mental disorders. The major hypothesis is that post-traumatic stress disorder (PTSD) leads to a reductio See details	National Institutes of Health	9/24/2009
EMORY UNIVERSITY	$784,177	Trans-NIH Recovery Act Research Support Project Title: Economic Consequences of Advanced Testing for Subclinical Cardiovascular Disease The current application is written as a response to requests for applications in the area of NIH Challenge Grants in Health and Science Research (RC1) in the B This spending item is part of a $995,992 allocation. See details	National Institutes of Health	9/25/2009
EMORY UNIVERSITY	$782,143	Trans-NIH Recovery Act Research Support This application addresses broad Challenge Area (15) Translational Science, 15-MH-109: Prefrontal cortex regulation of higher brain function and complex behaviors, which is directed to examine mechanisms by which the developing and mature prefrontal corte See details	National Institutes of Health	9/24/2009
EMORY UNIVERSITY	$776,051	Trans-NIH Recovery Act Research Support Although AlzheimerG??s Disease (AD) is an aggressive and devastating dementia that has an increased frequency with age and is one of the most common neurodegenerative diseases, it is remarkably difficult to diagnose with certainty, particularly in the ear See details	National Institutes of Health	9/04/2009
EMORY UNIVERSITY	$775,000	Trans-NIH Recovery Act Research Support HIV vaccine strategies have not yet succeeded in generating broadly neutralizing antibody responses in humans. A limited number of broadly neutralizing human monoclonal antibodies against HIV have been identified and have been the subject of intensive stu See details	National Institutes of Health	9/25/2009
EMORY UNIVERSITY	$775,000	Trans-NIH Recovery Act Research Support Cardiac hypertrophy and the subsequent heart failure (HF) cause more than 260,000 deaths a year in The United States. Award Title:FUNCTIONAL COUPLING BETWEEN Ito AND Ica IN CARDIOMYOCYTES Recent studies demonstrated that the pathological increase of intra See details	National Institutes of Health	6/01/2009
EMORY UNIVERSITY	$775,000	Trans-NIH Recovery Act Research Support This application addresses broad Challenge Area (14) Stem Cells and specific Challenge Topic, 14-AG-105 Exploratory studies of induced pluripotent stem (iPS) cells from healthy individuals and patients with mental/nervous system disorders. Chromatin insul See details	National Institutes of Health	9/28/2009
EMORY UNIVERSITY	$771,552	Trans-NIH Recovery Act Research Support The cutaneous microcirculation plays a central role in a range of skin diseases that are characterized by epidermal hyperproliferation or cutaneous inflammation. Many of these diseases are typified by increased vascular permeability, leading to cutaneous See details	National Institutes of Health	9/18/2009
EMORY UNIVERSITY	$771,516	Trans-NIH Recovery Act Research Support The persistence of health disparities in medically underserved minority communities remains one of the most vexing public health problems facing our nationthe etiology of racial/ethnic differences in health involves dynamic interactions between genetic, b This spending item is part of a $13,320,021 allocation. See details	National Institutes of Health	9/25/2010
EMORY UNIVERSITY	$749,260	Trans-NIH Recovery Act Research Support DESCRIPTION (provided by applicant): This proposal demonstrates a novel healthcare delivery system that has the potential to significantly advance stroke rehabilitation monitoring and therapy. The broad, long-term objective is to provide accessible, affor This spending item is part of a $2,745,978 allocation. See details	National Institutes of Health	5/24/2010
EMORY UNIVERSITY	$743,447	Trans-NIH Recovery Act Research Support Factor VIII (fVIII) is the protein that is missing or deficient in patients with hemophilia A. The development of inhibitory antibodies (Abs) to fVIII currenlty is considered the most significant complication in the management of patients with hemophilia See details	National Institutes of Health	6/01/2009
EMORY UNIVERSITY	$741,299	Trans-NIH Recovery Act Research Support The gastrointestinal epithelium functions as a dynamic barrier that serves as an interface between luminal contents and underlying tissue compartments, and is thus vital in maintaining mucosal homeostasis. Mucosal wounds have been observed following enter See details	National Institutes of Health	7/12/2010
GEORGIA ASSOCIATION FOR PRIMARY HEALTH CARE, INC.	$720,000	ARRA - Health Information Technology Extension Program The National Center for Primary Care (NCPC) at the Morehouse School of Medicine(MSM) is proposing the establishment of the Georgia Regional Extension Center (GREC). We have partnered with the Georgia Department of Community Health (DCH), proposeded statewid... Show more This spending item is part of a $21,492,872 allocation. See details	Health and Human Services, Department of	2/08/2010
EMORY UNIVERSITY	$718,328	Trans-NIH Recovery Act Research Support One of the long-term goals of researchers at Emory University, specifically within the FAME center, is to elaborate and reconcile the potentially conflicting but ultimately complementary paradigms of synthetic chemistry and evolutionary biology. This desi See details	National Institutes of Health	9/30/2009
EMORY UNIVERSITY	$706,021	Trans-NIH Recovery Act Research Support HIV incidence among men who have sex with men (MSM) continues to rise in the United States, and over 50% of new US HIV infections in 2006 were among MSM. A recent CDC analysis suggests that over half of HIV transmissions among MSM are from main partners. See details	National Institutes of Health	8/11/2009
EMORY UNIVERSITY	$700,826	Trans-NIH Recovery Act Research Support Either total body exposure to ionizing radiation or inhalation of radioactive particulates can result in significant radiation dose deposition to the lungs. While a number of side effects can be observed from this type of exposure, pulmonary fibrosis is This spending item is part of a $850,335 allocation. See details	National Institutes of Health	6/14/2010
EMORY UNIVERSITY	$700,002	Trans-NIH Recovery Act Research Support Sickle cell nephropathy is a common complication of sickle cell disease that affects both children and adults, and may lead to kidney failure. The mechanisms that cause kidney damage in sickle cell disease are not well understood. We will study kidney dam See details	National Institutes of Health	8/17/2009
EMORY UNIVERSITY	$689,948	Trans-NIH Recovery Act Research Support Preventing Depression in People with Epilepsy: An Extension of Project UPLIFT Funded by the Centers for Disease Control and Prevention (CDC) as a home-based treatment for depression in people with epilepsy, Project UPLIFT was developed to provide group d This spending item is part of a $967,019 allocation. See details	National Institutes of Health	9/20/2009
EMORY UNIVERSITY	$668,768	ARRA - Preventive Medicine Residency Program Title: Preventive Medicine Residency Training in Maternal, Child, and Family Health Brief Overview: This training project will provide preventive medicine residents with academic training (MPH degree at the Emory Rollins School of Public Health) and practt... Show more See details	Health Resources and Services Administration	7/02/2010
EMORY UNIVERSITY	$652,982	The Chemical Biology Consortium (CBC) will identify a cadre of members with the biological expertise and capability to rapidly develop sufficient information both in vitro and in vivo to determine the potential of novel discoveries, from the Cancer Genome This spending item is part of a $5,000,000 allocation. See details	National Institutes of Health	12/22/2009
EMORY UNIVERSITY	$643,253	Trans-NIH Recovery Act Research Support Free radicals that are made from oxygen have recently been found to be overproduced in several types of cancers, including those of the digestive tract. The major source of these radicals has recently been discovered to be a type of enzyme called a G?NoxG See details	National Institutes of Health	9/30/2009
EMORY UNIVERSITY	$635,483	Trans-NIH Recovery Act Research Support Metadata analysis of Glycan Structure (MAGS) is essential for defining the human glycome and will contribute to diagnosing altered glycosylation associated with many human diseases. There are two specific aims that we are adding to this competitive revisi See details	National Institutes of Health	9/30/2009
EMORY UNIVERSITY	$625,052	Trans-NIH Recovery Act Research Support Hospital length of stay (LOS) is a central factor in the increasingly important and complex interplay between quality of healthcare delivery and medical costs. The inpatient environment bolsters the intensity of care, and indeed longer hospital stays have This spending item is part of a $1,171,865 allocation. See details	National Institutes of Health	9/21/2010
PARTNERSHIP FOR COMMUNITY ACTION, INC.	$624,685	ARRA - Head Start Head Start Quality Improvement and COLA (ARRA): This award provides for ARRA Cost of Living Adjustment (COLA), and Quality Improvement Funding consistent with the provisions of Section 640 (a)(5) of the Head Start Act for the Head Start and Early Head St See details	Administration for Children and Families	6/16/2009
OAKHURST MEDICAL CENTERS, INC.	$605,040	ARRA Health Center Integrated Services Development Initiative[g1] ARRA - CAPITAL IMPROVEMENT PROGRAM (CIP). This funding will be utilized to expand the facility to accommodate three additional exam rooms; expand the waiting rooms for our pediatric and OB/GYN populations; repave the parking lot; add t three administrative ... Show more See details	Health Resources and Services Administration	6/25/2009
SCIMETRIKA, LLC	$599,696	TThe purpose of this task order is to obtain operational and evaluation support for HITECH Act grantees to enhance EHR-IIS interoperability for the Immunization Information Systems Support Branch, Immunization Services Division, National Center for Immuni See details	Centers for Disease Control and Prevention	7/29/2010
EASTER SEALS NORTH GEORGIA, INC.	$594,304	ARRA - Head Start ARRA Cost of Living Adjustment (COLA) and Quality Improvement Funding consistent with the provisions of Section 640(a)(5) of the Head Start Act. Award served 1,076 children in Fulton, Barrow, Madison, Jackson, Oconee and Walton counties, Georgia. These See details	Administration for Children and Families	7/02/2009
EMORY UNIVERSITY	$524,750	Trans-NIH Recovery Act Research Support Amongst the greatest risks to human public health is the possibility of large outbreaks of viruses or antibioticresistant bacteria (natural or engineered) occurring with speeds that would not allow the development and timely administration of prophylactic See details	National Institutes of Health	9/29/2009
ATLANTA RESEARCH AND EDUCATION FOUNDATION, INC.	$522,730	ARRA - Immunization This is an ARRA supplement to our currently-existing Emerging Infections Program (EIP) cooperative agreement (project period ends on December 30, 2011). With this supplemental funding, CDC is proposing to evaluate the effectiveness of 2 vaccines in the 10 This spending item is part of a $528,719 allocation. See details	Centers for Disease Control and Prevention	9/01/2009
EMORY UNIVERSITY	$519,640	Trans-NIH Recovery Act Research Support Project Title: Virologic Correlates of HIV Heterosexual Transmission The overall goal of this study is to determine whether women exposed to HIV in the semen of there husbands but do not get infected (so called exposed uninfected women) have developed an See details	National Institutes of Health	5/17/2010
EMORY UNIVERSITY	$516,820	Trans-NIH Recovery Act Research Support This application addresses broad Challenge Area (04) Clinical Research and specific Challenge Topic, 04-HD- 102: Development of Pediatric Medical Devices. The title of this project is G?Kidney Injury and Dysfunction Support (KIDS) - Development of a safe, This spending item is part of a $1,000,000 allocation. See details	National Institutes of Health	9/21/2009
EMORY UNIVERSITY	$509,947	Trans-NIH Recovery Act Research Support Title: Melatonin and Nighttime Blood Pressure in African Americans. Our ARRA-funded project is a randomized, double-blind, placebo-controlled, crossover clinical trial that is testing the effect of 24 mg/night of melatonin supplementation on nighttime bl See details	National Institutes of Health	9/11/2009
EMORY UNIVERSITY	$500,000	Trans-NIH Recovery Act Research Support FEI TRANSMISSION ELECTRON MICROSCOPE WITH TOMOGRAPHY CAPABILITY The award is for an electron microscope, an instrument that can be used for new discoveries in biology or in the study of small structures. There is a dedicated group of scientists who will u See details	National Institutes of Health	4/28/2009
EMORY UNIVERSITY	$499,863	Trans-NIH Recovery Act Research Support Tranplant Tolerance in Non-Human Primates For most patients with end stage renal disease, organ transplantation is the preferred therapy. Recent evidence suggests antibody-mediated rejection is a growing problem in clinical transplantation. The goal of th See details	National Institutes of Health	7/26/2010
EMORY UNIVERSITY	$499,534	Trans-NIH Recovery Act Research Support This is extra funding for the Emory HIV/AIDS Clinical Trials Unit supplement designated for the HPTN protocols 061 and 064. The award will provide support for the analysis and closeout functions needed for these two protocols. See details	National Institutes of Health	5/24/2010
ATLANTA RESEARCH AND EDUCATION FOUNDATION, INC.	$497,911	ARRA - Preventing Healthcare-Associated Infections In response to increasing concerns about the public health impact of healthcare-associated infections (HAIs), the U.S. Department of Health and Human Services (HHS) developed a 2009 Action Plan that tasked states to develop individual plans to reducece HAIs... Show more See details	Centers for Disease Control and Prevention	8/31/2009
EMORY UNIVERSITY	$497,082	Trans-NIH Recovery Act Research Support Validation & Pilot Testing of Methods for Assessing Infants' Dietary Pesticide Exposure Despite evidence of widespread dietary exposure among children and adults, little is currently known about dietary exposure of neonates and infants to pesticides. Thi See details	National Institutes of Health	9/21/2009
EMORY UNIVERSITY	$494,676	Trans-NIH Recovery Act Research Support The focus of the present proposal is related directly to the component of our P51 parent grant intended to enhance research studies applicable to the solution of human health problems, i.e., translational research. Specifically, we are requesting funds to See details	National Institutes of Health	9/24/2009
EMORY UNIVERSITY	$486,623	Trans-NIH Recovery Act Research Support SPF Breeding Colonies at the Yerkes NPRC G?? Supplement Support to enable us to better characterize the MHC region of the specific pathogen free (SPF) colony of rhesus macaques housed at the Yerkes National Primate Research Center by using a two-fold app See details	National Institutes of Health	8/28/2009
EMORY UNIVERSITY	$477,754	Trans-NIH Recovery Act Research Support The title of this award: REPAIR OF CLUSTERED DNA DAMAGES. Melanoma is the most fatal form of skin cancer. Despite much research has been directed to identify the etiological factors that lead to melanoma formation, it is still not clear what factors ot See details	National Institutes of Health	6/05/2009
EMORY UNIVERSITY	$441,691	Trans-NIH Recovery Act Research Support The project is entitled 'Accessible Handling of Misclassified or Missing Binary Variables in CER Studies'. The goal of this project is to provide statistical methods to aid comparative effectiveness research (CER) investigators with common problems encoun See details	National Institutes of Health	9/24/2010
EMORY UNIVERSITY	$433,692	Trans-NIH Recovery Act Research Support Title: The Role Of Leukocyte Sequestration In The Control Of Viral Infections Abstract In the period immediately following infection, many viruses cause a transient, type I interferon-dependent lymphopenia. The reason that mammalian hosts adopt such a str See details	National Institutes of Health	5/29/2009
EMORY UNIVERSITY	$432,250	Trans-NIH Recovery Act Research Support Design of new treatment agents for drug abuse The development of effective medications for the treatment of drug addiction disorders is of great importance to society. Great advances have been made in the treatment of many CNS diseases that were previou This spending item is part of a $772,650 allocation. See details	National Institutes of Health	7/16/2009
EMORY UNIVERSITY	$426,250	Trans-NIH Recovery Act Research Support The Role of JAM-A in Regulation of Intestinal Antigen Presenting Cells and Inflammation Numerous observations have suggested that inflammatory bowel disease is a multifactorial process encompassing at least three major interacting elements: environmental See details	National Institutes of Health	9/01/2009
EMORY UNIVERSITY	$426,250	Trans-NIH Recovery Act Research Support 'Identification of localized miRNAs for neuronal development and plasticity'. This research will advance our understanding of the critical importance played by miRNAs in local protein synthesis underlying neuronal development, which may be altered in dise See details	National Institutes of Health	5/21/2009
EMORY UNIVERSITY	$426,250	Trans-NIH Recovery Act Research Support Schizophrenia biomarkers discerned by cellular networks in DiGeorge syndrome. To understand the causes of schizophrenia we should ultimately consider its genetic underpinnings and developmental course (i.e. from the prenatal period though adulthood). In r See details	National Institutes of Health	4/28/2009
EMORY UNIVERSITY	$426,250	Trans-NIH Recovery Act Research Support Improving Self Management and Outcomes in Heart Failure Patients with Diabetes Abstract This proposal addresses the problems of poor patient outcomes and high readmission rates in patients with concomitant heart failure (HF) and diabetes mellitus (DM). T See details	National Institutes of Health	9/01/2009
EMORY UNIVERSITY	$426,250	Trans-NIH Recovery Act Research Support The Role of JAM-A in Regulation of Intestinal Antigen Presenting Cells and Inflammation Numerous observations have suggested that inflammatory bowel disease is a multifactorial process encompassing at least three major interacting elements: environmental See details	National Institutes of Health	9/01/2009
EMORY UNIVERSITY	$420,456	Trans-NIH Recovery Act Research Support The Advanced Technology QA Consortium (ATC), through the Image-Guided Therapy Center (ITC) at Washington University, has developed an advanced medical informatics infrastructure that enables institutions to submit, and QA Centers to receive, share, and a This spending item is part of a $1,618,515 allocation. See details	National Institutes of Health	9/23/2009
SWORD & SHIELD ENTERPRISE SECURITY, INC.	$416,629	Checkpoint IT Security Products See details	Centers for Disease Control and Prevention	9/29/2009
EMORY UNIVERSITY	$401,060	Trans-NIH Recovery Act Research Support The Atlanta Clinical and Translational Science Institute's (ACTSI) community engagement efforts strive to increase the capacity of communities to participate in clinical and translational research. ACTSI's Community Engagement and Research Program (CERP), This spending item is part of a $599,998 allocation. See details	National Institutes of Health	9/04/2009
EMORY UNIVERSITY	$397,691	Trans-NIH Recovery Act Research Support This project will investigate the efficacy of UBS109, a water soluble nuclear factor kappa B (NF-kB ) antagonist structurally related to curcumin, the principal curcuminoid of the Indian curry spice turmeric, to block CNS and behavioral changes in an anim See details	National Institutes of Health	8/14/2009
EMORY UNIVERSITY	$393,477	Trans-NIH Recovery Act Research Support Patients with an acute coronary syndrome (ACS) and comorbid depression have a 2-fold higher risk for recurrent ACS and mortality, worse quality of life, and higher costs of care than nondepressed ACS patients. The strength of these findings prompted the A This spending item is part of a $4,136,888 allocation. See details	National Institutes of Health	9/28/2009
EMORY UNIVERSITY	$391,250	Trans-NIH Recovery Act Research Support Title: Towards the development of a novel treatment for epilepsy. The voltage-gated sodium channels SCN1A, SCN2A, SCN3A, and SCN8A are key regulators of neuronal excitability in the central nervous system (CNS). Mutations in SCN1A, SCN2A, and SCN3A are a This spending item is part of a $426,250 allocation. See details	National Institutes of Health	7/19/2009
CARTER CONSULTING, INC.	$386,285	NCHM Program Communications (ARRA line 11 old 145) See details	Centers for Disease Control and Prevention	9/04/2009
MERLIN INTERNATIONAL, INC.	$357,347	Tipping Point Product, Maintenance and Installation services. See details	Centers for Disease Control and Prevention	8/05/2010
EMORY UNIVERSITY	$352,000	Trans-NIH Recovery Act Research Support This application is for funding of a study to characterize the human immune response before and after 2010-2011 influenza A/California/H1N1 seasonal vaccination by developing comprehensive immune profiles utilizing systems biology and bioinformatics appro This spending item is part of a $3,496,853 allocation. See details	National Institutes of Health	7/12/2010
EMORY UNIVERSITY	$338,529	Trans-NIH Recovery Act Research Support Title: Analysis of Ubiquitinated Proteome Like phosphorylation, protein ubiquitination is a reversible process to regulate essentially all cellular events. Misregulation of ubiquitination plays an important role in the pathogenesis of a variety of diseas See details	National Institutes of Health	9/24/2009
CARTER CONSULTING, INC.	$330,544	Technical Assistance Management of ARRA funded grants Support for the Education, Information, and Partnership Branch (EIPB), Immunization Services Division (ISD), National Center for Immunization and Respiratory Diseases (NICRD) See details	Centers for Disease Control and Prevention	1/28/2010
NORTHROP GRUMMAN INFORMATION TECHNOLOGY INC	$328,037	The purpose of this project is to enhance Immunization Information System Support Branch (IISSB)'s ability to analyze de-identified record-level immunization data in order to conduct more effective and timely monitoring of Immunization Information System See details	Centers for Disease Control and Prevention	11/12/2009
MERIDIAN EDUCATION RESOURCE GROUP, INC.	$324,025	ARRA Health Center Integrated Services Development Initiative[g1] Grant Name - Capital Improvement Program Purpose - to Implement Electronic Health Record System. Goals - to improve service delivery and increase patient health outcome through the implementation of electronic health record system. Thehe importance of achie... Show more See details	Health Resources and Services Administration	6/25/2009
CARTER CONSULTING, INC.	$321,041	Technical assistance and monitoring for 317 ARRA strengthening the evidence base for the National Immunization Program (SEB) See details	Centers for Disease Control and Prevention	9/23/2009
EMORY UNIVERSITY	$310,223	Trans-NIH Recovery Act Research Support Epstein-Barr virus (EBV) infects over 95% of the adult population worldwide, and has been estimated to be a contributing agent in ~1% of all human cancer. Its carcinogenic potential is significantly elevated by immunosuppression, as is found in the conte This spending item is part of a $991,151 allocation. See details	National Institutes of Health	9/28/2009
EMORY UNIVERSITY	$310,020	Trans-NIH Recovery Act Research Support This supplement request is to accelerate the process of the parent grant entitled G?A new role of MEPE/OF45 as a co-factor of CHK1 for DNA damage response,G? by hiring new employees. The research design/proposed scientific activities, methods and data ana See details	National Institutes of Health	9/09/2009
EMORY UNIVERSITY	$310,000	Trans-NIH Recovery Act Research Support Neutrophil interactions with intestinal epithelial cells The etiology of human inflammatory bowel disease (IBD) includes both aberrant leukocyte responses and epithelial barrier dysfunction. Junctional Adhesion Molecule (JAM) family of proteins have been See details	National Institutes of Health	9/25/2009
EMORY UNIVERSITY	$309,227	Trans-NIH Recovery Act Research Support This project G?? G??Performance Indices of Social Disability in Toddlers with AutismG?? G?? addresses Challenge AreaG??(04) Clinical ResearchG?? and Specific Challenge Topic G??Autism: Addressing the Challenge (04-MH-101*)G??; and Challenge Area G??(01) B See details	National Institutes of Health	2/14/2012
EMORY UNIVERSITY	$297,600	Trans-NIH Recovery Act Research Support Title: CART Regulation of Wakefulness DESCRIPTION (provided by applicant): CART (Cocaine and Amphetamine-Regulated Transcript) peptides appear to mediate behaviors associated with psychostimulant drugs including: hypothalamically mediated suppression of f See details	National Institutes of Health	9/28/2009
EMORY UNIVERSITY	$292,030	Trans-NIH Recovery Act Research Support Genetics of Hypertension Risk Factors and Sequela in African Americans See details	National Institutes of Health	8/10/2011
EMORY UNIVERSITY	$291,952	Trans-NIH Recovery Act Research Support This is an administrative supplement for R21 HL093665 (PI, V. Vaccarino), entitled G?Sex Differences in Myocardial Ischemia Triggered by Emotional Factors after MI.G? One third to two thirds of patients with CHD have myocardial ischemia that is induced by See details	National Institutes of Health	7/16/2009
EMORY UNIVERSITY	$290,159	Trans-NIH Recovery Act Research Support This award titled: 'NUCLEAR MAGNETIC RESONANACE SPECTROSCOPY BASED METABOLOMICS' is funded under the American Recovery and Reinvestment Act of 2009 (ARRA) to develop a novel metabolomics approach that may improve the early diagnosis of Alzheimer's disease See details	National Institutes of Health	5/18/2009
CLOUDBURST CONSULTING GROUP, INC.	$277,369	The purpose of this task order is to develop training curricula, materials and other resources to be utilized by the ARRA funded states and territories under the Communities Putting Prevention to Work program. The objective of the task order is to increa See details	Centers for Disease Control and Prevention	7/14/2010
EMORY UNIVERSITY	$273,352	Trans-NIH Recovery Act Research Support Award Title: The PINK1 Mitochondrial Signaling Pathway Grant Number: 3R01GM082828-02S1 Mitochondria are dynamic multi-functional organelles crucial for cell life and death, yet the signaling pathways and regulatory mechanisms that control mitochondrial f See details	National Institutes of Health	8/31/2009
EMORY UNIVERSITY	$273,118	Trans-NIH Recovery Act Research Support 'Nox4 and cardiac fibrosis'. Congestive heart failure is a major cause of hospitalization (over 500,000 admissions per year) and affect over 5 million patients in US. In the current application we will study the mechanism of development and progression of See details	National Institutes of Health	7/13/2009
EMORY UNIVERSITY	$270,000	Trans-NIH Recovery Act Research Support Emory-Ethiopia Global Interdisciplinary Partnership. Building on unique partnerships with the CDC, CARE, the Carter Center, and the Task Force for Global Health, Emory University is already one of the nation's leading universities for reducing disease in See details	National Institutes of Health	9/27/2010
NORTHROP GRUMMAN INFORMATION TECHNOLOGY INC	$269,691	To conduct programming activities to enhance the CDC's-OSH's State Tobacco Activities Tracking and Evaluation (STATE) System to support the inclusion and reporting of data from state tobacco cessation quitlines. See details	Centers for Disease Control and Prevention	9/27/2010
SCIMETRIKA, LLC	$269,232	The contractor will provide scientific services to satisfy the epidemiologic objectives of the National Center for Immunization and Respiratory Diseases, Division of Viral Diseases (DVD), Epidemiology Branch (EB). The primary objective is to provide tech See details	Centers for Disease Control and Prevention	9/22/2009
EMORY UNIVERSITY	$264,184	Trans-NIH Recovery Act Research Support Excitation-contraction coupling in human ventricle development Postnatal changes in the mammalian heart make it difficult to extrapolate pharmacological and surgical therapies from adults to infants. Excitation-contraction coupling is the method b See details	National Institutes of Health	7/16/2009
EMORY UNIVERSITY	$261,084	Trans-NIH Recovery Act Research Support TRAINING IN SYSTEMS AND INTEGRATIVE BIOLOGY: NEUROSCIENCE: This award will support three addditional outstanding predoctoral students in the interdepartmental Graduate Program in Neuroscience at Emory University for the next two years. The objective of th See details	National Institutes of Health	8/13/2009
MERLIN INTERNATIONAL, INC.	$260,913	providing product and maintenance support for Juniper products. See details	Centers for Disease Control and Prevention	4/07/2010
EMORY UNIVERSITY	$259,760	Trans-NIH Recovery Act Research Support In order to protect civilian and military populations, it is critical to improve the diagnosis of NIAID Category A-C priority pathogens. More rapid, more sensitive, more specific, and more informative diagnosis than currently possible will allow earlier This spending item is part of a $4,818,047 allocation. See details	National Institutes of Health	8/14/2009
EMORY UNIVERSITY	$258,970	Trans-NIH Recovery Act Research Support Abstract this project aims to establish a Lung Cancer Mutation Consortium (LCMC) consisting of 13 institutions with a major interest in lung cancer and genomic testing of lung cancer as documented by having major NCI grants in lung cancer. The LCMC member This spending item is part of a $4,894,665 allocation. See details	National Institutes of Health	9/29/2009
DESA, INC.	$258,832	CPPW Objective Review See details	Centers for Disease Control and Prevention	12/22/2009
EMORY UNIVERSITY	$250,625	Trans-NIH Recovery Act Research Support The title of the award is: Comparison of B Cell Differentiation in Mice and Humans. Our previous studies indicated that human B cells, but not mouse B cells, preferentially express immunoglobulin Fc Receptor-Like (FCRL) transmembrane receptors that have a See details	National Institutes of Health	9/11/2009
EMORY UNIVERSITY	$250,582	Trans-NIH Recovery Act Research Support Project Title: CTL and HIV Polymorphisms in Heterosexual Transmission The major goal of this project is to determine whether certain persons have a genetic background that can make them less likely to be infected by HIV. Several human genes encode for fa See details	National Institutes of Health	5/17/2010
CNI INFORMATION TECHNOLOGY, LLC	$250,008	Cyber Security Support for DHHS Cyber Security Forensics Expert (THIS REPORTS REFLECTS THE CUMMULATIVE INVOICED AMOUNTS SINCE THE START OF PERFORMANCE ON THE CONTRACT) See details	Centers for Disease Control and Prevention	2/01/2010
CNI INFORMATION TECHNOLOGY, LLC	$250,008	Cyber Security Support for DHHS HARDWARE/SOTFWARE ENGINEER. (THIS REPORTS REFLECTS THE CUMMULATIVE AMOUNTS INVOICED SINCE THE START OF PERFORMANCE ON THE TASK.) See details	Centers for Disease Control and Prevention	2/01/2010
DEKALB, COUNTY OF	$250,000	ARRA Strengthening Communities Fund The goal of the program is to build our capacity to partner with community based and faith-based non-profits and to provide training and technical assistance to help nonprofit faith-based and community organizations better serve those in need and to incre See details	Administration for Children and Families	9/23/2009
EMORY UNIVERSITY	$249,685	Trans-NIH Recovery Act Research Support This application addresses broad Challenge Area (06) Enabling Technologies and specific Challenge Topic 06-AT-101: In this project, we propose two project areas based on the use of Magnetic Resonance Imaging modalities at both the cerebral (brain) and sub This spending item is part of a $999,319 allocation. See details	National Institutes of Health	9/16/2009
EMORY UNIVERSITY	$247,488	Trans-NIH Recovery Act Research Support Award Title: Structure/function analysis of the Na/bicarbonate cotransporters. Funding Purpose: The electrogenic sodium/bicarbonate transporter NBCe1 plays an essential role in bicarbonate reabsorption in the kidney that regulates systemic pH in the bo See details	National Institutes of Health	9/30/2009
OAKHURST MEDICAL CENTERS, INC.	$246,585	ARRA Health Center Integrated Services Development Initiative[g1] ARRA - Increase Demand for Services funding has allowed Oakhurst Medical Centers, Inc. to improve patient services for OB and GYN by increasing services from two and one half days per week at the Stone Mountain site only to five days p per week at the Stone... Show more See details	Health Resources and Services Administration	3/23/2009
EMORY UNIVERSITY	$245,138	Trans-NIH Recovery Act Research Support Spinal Muscular Atrophy (SMA) is a common inherited neurodegenerative disease caused by mutations or deletions in the SMN1 gene that encodes for the ubiquitous Survival of Motor Neuron Protein (SMN), which is essential for the assembly of spliceosomal snR See details	National Institutes of Health	9/28/2009
EMORY UNIVERSITY	$241,857	Trans-NIH Recovery Act Research Support This application addresses broad Challenge Area (06) Enabling Technologies and specific Challenge Topic 06-AT-101: In this project, we propose two project areas based on the use of Magnetic Resonance Imaging modalities at both the cerebral (brain) and sub This spending item is part of a $999,319 allocation. See details	National Institutes of Health	9/16/2009
EMORY UNIVERSITY	$241,177	Trans-NIH Recovery Act Research Support Mechanisms of Meditation Mechanisms of Meditation This project will significantly expand the scope of our NCCAM-funded R01 Project entitled ?Mechanisms of Meditation? (R01AT004698-01). It adds an innovative naturalistic observation method to assess the ef This spending item is part of a $551,083 allocation. See details	National Institutes of Health	9/16/2009
EMORY UNIVERSITY	$240,590	Trans-NIH Recovery Act Research Support Genome-wide analysis of RXRa binding in mouse liver chromatin with ChIP-SEQ A substantial proportion of metabolic and responsive gene regulation in the liver occurs via members of the Nuclear Receptor (NR) superfamily, specifically those regulated by RXRa See details	National Institutes of Health	11/25/2011
BOOZ ALLEN HAMILTON INC.	$237,911	Improvement of laboratory based detection and characterization of bacterial agents of vaccine preventable diseases including pertussis and meningitis in public health laboratories in the US. This spending item is part of a $314,149 allocation. See details	Centers for Disease Control and Prevention	9/24/2009
EMORY UNIVERSITY	$235,665	Trans-NIH Recovery Act Research Support INSTITUTIONAL RESEARCH AND ACADEMIC CAREER DEVELOPMENT The Fellowships in Research and Science Teaching (FIRST) program is a consortium of two research- intensive institutions, Emory University and the Morehouse School of Medicine (MSM), and the three mi This spending item is part of a $301,075 allocation. See details	National Institutes of Health	8/24/2009
EMORY UNIVERSITY	$235,436	Trans-NIH Recovery Act Research Support AMYGDALA: SEX DIFFERENCES IN BEHAVIOR, COGNITION, This is a competitive revision proposal of currently funded R01-MH050268 entitled G?Amygdala sex differences in behavior cognition and neuroendocrine developmentG? in response to NOT-OD-10-032 entitled G?N This spending item is part of a $277,495 allocation. See details	National Institutes of Health	9/27/2010
EMORY UNIVERSITY	$232,500	Trans-NIH Recovery Act Research Support Transplant Tolerance in Non-human primates. This program project grant seeks to develop novel immunomodulatory strategies to induce immune tolerance after transplantation. Immune tolerance is defined as the acceptance of an allogeneic allograft without re See details	National Institutes of Health	9/11/2009
EMORY UNIVERSITY	$227,204	Trans-NIH Recovery Act Research Support Every person differs in his or her response to pathogens and in the likelihood that they will suffer from complex diseases such as cancer, heart disease or diabetes. Individual susceptibility to disease is determined in part by genetics, and we can map wi This spending item is part of a $1,500,000 allocation. See details	National Institutes of Health	9/25/2009
EMORY UNIVERSITY	$226,774	Trans-NIH Recovery Act Research Support Title: Ubiquitin-dependent Proteolysis: Specificity and Mechanism. Post-translational ubiquitination of proteins generates a signal that targets the modified protein to multiple cellular fates. Polyubiquitin binding proteins are necessary to couple the p See details	National Institutes of Health	9/30/2009
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION	$226,410	Programming and Data Management of Rotavirus Vaccine Surveillance System See details	Centers for Disease Control and Prevention	10/19/2009
EMORY UNIVERSITY	$223,748	Trans-NIH Recovery Act Research Support Project iMPPACS provides the first large-scale test of a culturally targeted TV and radio campaign to reduce HIV-associated sexual risk behavior among 1,600 African-American teens in four mid-sized cities in the U.S. Initial findings offer evidence of pro See details	National Institutes of Health	9/28/2009
RED RIVER COMPUTER CO., INC.	$219,120	ADP SERVERS, ROUTERS, SWITCHES, CONSOLES, SOFTWARE AND MAINTENANCE See details	Centers for Disease Control and Prevention	5/14/2010
MERLIN INTERNATIONAL, INC.	$209,902	Gigamon Product and Maintenance See details	Centers for Disease Control and Prevention	7/21/2010
MERLIN INTERNATIONAL, INC.	$209,163	Agiliance products maintenance and services. See details	Centers for Disease Control and Prevention	9/09/2010
EMORY UNIVERSITY	$206,863	We have been awarded a contract to provide tumor types to the NCI for The Cancer Genome Atlas (TCGA) project. Specifically to establish a Tissue Source Site (TSS) Network capable of delivering clinically annotated biospecimens through either or both retr This spending item is part of a $2,725,275 allocation. See details	National Institutes of Health	9/27/2010
EMORY UNIVERSITY	$201,247	Trans-NIH Recovery Act Research Support Calcification of the medial layer of arteries is common in patients with chronic kidney disease (CKD) and correlates with cardiovascular events and death. Research in our laboratories has demonstrated that vascular calcification is normally inhibited by e This spending item is part of a $977,102 allocation. See details	National Institutes of Health	9/21/2009
EMORY UNIVERSITY	$199,950	Trans-NIH Recovery Act Research Support Title: THE ROLE OF MOUSE ARL13B IN CELL DIVERSIFICATION Cilia play well-established roles in motility and cell signaling in the mammalian nervous system. Our current understanding of how the neuroepithelium gives rise to specific neurons while maintain See details	National Institutes of Health	8/11/2009
EMORY UNIVERSITY	$199,132	Trans-NIH Recovery Act Research Support In Crisis Intervention Team (CIT) training, police officers participate in 40 hours of specialized training provided by local mental health professionals, family members/advocates, and mental health consumer groups. Upon completion, these officers serve a This spending item is part of a $620,379 allocation. See details	National Institutes of Health	7/21/2011
EMORY UNIVERSITY	$195,000	Trans-NIH Recovery Act Research Support MHC Class II Transactivator Function and Regulation This supplement will extend the work that was begun as Aim 2 in AI34000-15. Major histocompatibility complex (MHC) molecules represent the major barrier to organ transplantation. As such, understanding t See details	National Institutes of Health	9/21/2009
EMORY UNIVERSITY	$193,750	Trans-NIH Recovery Act Research Support Anti-microbial T cell responses play a major role in determining the outcome of infection. Chronic infections are often distinguished by T cell responses that are not able to fully eliminate the pathogen. The mechanisms that explain this failure of T cell This spending item is part of a $422,938 allocation. See details	National Institutes of Health	5/29/2009
EMORY UNIVERSITY	$193,750	Trans-NIH Recovery Act Research Support The development of an effective HIV vaccine is one of the greatest global health challenges. However despite decades of research, no vaccine has yet been able to elicit protective immunity to HIV. Recently, efforts to develop vaccines against HIV have foc This spending item is part of a $763,750 allocation. See details	National Institutes of Health	9/30/2010
QUEST SOFTWARE, INC.	$193,536	Quest Software and Maintenance This spending item is part of a $209,664 allocation. See details	Health and Human Services, Department of	7/29/2010
EMORY UNIVERSITY	$192,292	Trans-NIH Recovery Act Research Support Title: SUPPORT OF YERKES NATIONAL PRIMATE RESEARCH CENTER One of the central goals of the Yerkes National Primate Research Center is to provide educational and training opportunities. The Center is actively involved in training and continuing education See details	National Institutes of Health	6/08/2009
EMORY UNIVERSITY	$192,232	Recovery Act Comparative Effectiveness Research - AHRQ Coronary CT angiography (CCTA) represents a potentially disruptive technology in terms of its impact on the clinical evaluation and management of coronary artery disease (CAD). This was highlighted by its inclusion in the Consensus Report on Inititial Natio... Show more This spending item is part of a $9,666,726 allocation. See details	Agency for Healthcare Research and Quality	9/28/2010
EMORY UNIVERSITY	$190,000	Trans-NIH Recovery Act Research Support The robust regeneration potential of fetal tissue suggests that developmental biology may help guide strategies for tissue regeneration in adults. Decreases in regenerative capacity post-utero and with increasing age are likely due to multiple factors, ho This spending item is part of a $1,274,015 allocation. See details	National Institutes of Health	9/09/2009
LOGISTICS HEALTH, INC.	$188,932	Staffing contract for one Microbiologist in support of the HPV Program. See details	Centers for Disease Control and Prevention	9/28/2009
EMORY UNIVERSITY	$188,515	Recovery Act Comparative Effectiveness Research - AHRQ The STONE study, a multi-center randomized controlled trial (RCT), is a comparative effectiveness trial of three different imaging strategies in patients with suspected urolithiasis (kidney stones), seen in the Emergency Department. The study fofocuses on ... Show more This spending item is part of a $9,154,210 allocation. See details	Agency for Healthcare Research and Quality	9/28/2010
BLUE TECH INC.	$188,287	Splunk Software See details	Centers for Disease Control and Prevention	5/10/2010
EMORY UNIVERSITY	$187,500	Trans-NIH Recovery Act Research Support DOPAMINERGIC MODULATION OF COGNITIVE ASPECTS OF SKILL ACQUISITION IN PARKINSON'S DISEASE DOPAMINERGIC MODULATION OF COGNITIVE ASPECTS OF SKILL ACQUISITION IN PD ParkinsonG??s disease (PD) is characterized by cardinal motor features considered reflective o See details	National Institutes of Health	5/15/2009
EMORY UNIVERSITY	$183,749	Trans-NIH Recovery Act Research Support Title: Combination therapy in human ES cell transplantation after neonatal stroke Embryonic stem cell transplantation has been widely investigated as a novel therapeutic strategy in ischemic stroke. The original Specific Aims address three key issues in s See details	National Institutes of Health	9/28/2009
EMORY UNIVERSITY	$182,086	Trans-NIH Recovery Act Research Support Hybrid Revascularization vs Percutaneous Coronary Intervention: A Planning Grant This application addresses broad Challenge Area (04) Clinical Research and specific Challenge Topic, 04-HL-115: Treatment of stenosed coronary arteries with hybrid coronary This spending item is part of a $1,000,000 allocation. See details	National Institutes of Health	9/21/2009
EMORY UNIVERSITY	$178,808	Trans-NIH Recovery Act Research Support Title: Patients' Experiences of Emergency Research: The PEER Study There is a critical need for clinical research on treatment of acute neurological conditions such as traumatic brain injury, seizures, and stroke. The National Institute of Neurological Di See details	National Institutes of Health	6/15/2009
EMORY UNIVERSITY	$178,250	Trans-NIH Recovery Act Research Support Determinants of T cell fate in transplantation tolerance The project supported by these ARRA funds is investigating new methods of inhibiting the immune-mediated rejection of transplanted organs. Transplantation is a cure for many end-stage organ disease See details	National Institutes of Health	9/21/2009
EMORY UNIVERSITY	$176,036	Trans-NIH Recovery Act Research Support ADPKD is the most prevalent inherited renal disease, accounting for 4% of the ESRD population. Detection of renal cysts utilizing renal imaging has been the most common method of diagnosis of this disease however, cyst appearance is often delayed with aff This spending item is part of a $695,928 allocation. See details	National Institutes of Health	8/17/2009
EMORY UNIVERSITY	$174,056	Trans-NIH Recovery Act Research Support PREDOCTORAL TRAINING PROGRAM IN GENETICS Opportunities in the fields of genetics and molecular biology in academia, government, and in the private sector have increased with the explosion of genetic information and the potential to use this information fo See details	National Institutes of Health	8/13/2009
EMORY UNIVERSITY	$172,731	Trans-NIH Recovery Act Research Support The proposed program of research will address conservative therapies for OAB and urge incontinence in men. We will plan a 2-stage, randomized clinical trial to examine the effectiveness of behavioral treatment, drug therapy, and combined behavioral and dr This spending item is part of a $1,064,142 allocation. See details	National Institutes of Health	9/30/2009
ST. JOHN GROUP, LLC, THE	$172,680	Audience Analysis/testing and development of social media actvities. Usability testing of proposed immunization web site changes, social media plan recommendations, social media tool analysis and recommendations and web design input/ recommendations. Web This spending item is part of a $703,200 allocation. See details	Centers for Disease Control and Prevention	11/10/2009
EMORY UNIVERSITY	$172,186	Trans-NIH Recovery Act Research Support Tuberculosis (TB) is an enormous global public health problem including in the independent country of Georgia, a former Soviet republic, which has high rates of TB including drug-resistant TB (MDR- and XDR-TB). This ARRA award is a supplement (U.S. Globa See details	National Institutes of Health	9/03/2009
EMORY UNIVERSITY	$172,186	Trans-NIH Recovery Act Research Support Tuberculosis (TB) is an enormous global public health problem including in the independent country of Georgia, a former Soviet republic, which has high rates of TB including drug-resistant TB (MDR- and XDR-TB). This ARRA award is a supplement (U.S. Globa See details	National Institutes of Health	9/03/2009
UNISYS CORPORATION	$171,324	The work performed will support the implementation of immunization activities funded through ARRA, including reaching more children and adults with immunization; enhancing information, education and communications about immunization; and strengthening the This spending item is part of a $218,209 allocation. See details	Centers for Disease Control and Prevention	9/24/2009
EMORY UNIVERSITY	$169,829	Trans-NIH Recovery Act Research Support The purpose of the funding is to provide employment for on additional resident in an already existing veterinary training program, thus increasing the return on investment from the parent R25 supported program, while offering a new employment opportunity See details	National Institutes of Health	8/20/2009
Lightning Technology Solution Inc	$165,000	In support of the Public Health Laboratory Interoperability Solutions and Solution Architecture (PHLISSA) Task Order, SAIC will support the development of standards-based architectures to continue the significant progress toward full interoperability amon This spending item is part of a $3,672,289 allocation. See details	Centers for Disease Control and Prevention	7/09/2010
EMORY UNIVERSITY	$163,189	Trans-NIH Recovery Act Research Support Increases in childhood obesity are a public health concern worldwide. In the U.S., 17.6 percent of adolescents have high BMIs for their age. Obesity early in life is associated with poorer physical and mental health and social wellbeing, including respira This spending item is part of a $353,499 allocation. See details	National Institutes of Health	7/16/2009
EMORY UNIVERSITY	$162,855	Trans-NIH Recovery Act Research Support Title: Novel VLP vaccines for pandemic influenza virus (The ARRA award was made as a supplement to an ongoing project (AI068003). The 2009 influenza outbreak strain is the result of human infection with a new H1N1 strain of influenza virus containing some See details	National Institutes of Health	9/11/2009
EMORY UNIVERSITY	$159,020	Trans-NIH Recovery Act Research Support This project, Prevention Trial of Family Focused Treatment in Youth at Risk for Psychosis, is a multi-site study (UCLA, Yale, Emory, University of North Carolina) testing the efficacy of a family-focused psychosocial intervention in the prevention of func This spending item is part of a $969,718 allocation. See details	National Institutes of Health	9/30/2009
STAFF TECH, INC.	$158,931	Maintain and enhance the HPV Vaccine Impact Monitoring project See details	Centers for Disease Control and Prevention	11/18/2009
EMORY UNIVERSITY	$157,301	To design and test a method of intervention that has the capacity to promote engagement and adherence to treatment, foster recovery and reduce or prevent disability in patients experiencing a first episode of schizophrenia and related psychotic disorders. This spending item is part of a $16,872,951 allocation. See details	National Institutes of Health	7/13/2009
EMORY UNIVERSITY	$155,873	Trans-NIH Recovery Act Research Support RETINOID EFFECTS ON INFLAMMATION AND CELL GROWTH ASSOCIATED WITH ENDOMETRIOSIS. Retinoids are essential to the differentiation and development of reproductive tissue, including that from the endometrium and ovaries. In portions of the parent grant relatin See details	National Institutes of Health	7/29/2010
EMORY UNIVERSITY	$155,638	Trans-NIH Recovery Act Research Support Funding for this protocol is to allow enrollment of an additional group of patients who have malignancies that are positive for BRCA mutations. Specific Aims: This protocol will evaluate the combination chemotherapy regimen of the PARP inhibitor ABT-888 This spending item is part of a $749,856 allocation. See details	National Institutes of Health	7/17/2009
EMORY UNIVERSITY	$155,532	Trans-NIH Recovery Act Research Support FUNCTIONAL CHARACTERIZATION OF THE HEPATITIS C VIRUS E1-E2 GLYCOPROTEINS The hepatitis C virus (HCV) is an important pathogen that has infected approximately 170 million people worldwide. In spite of extensive efforts, surprisingly little is known about t See details	National Institutes of Health	9/21/2010
EMORY UNIVERSITY	$155,000	Trans-NIH Recovery Act Research Support Vitamin D Status in Pulmonary Fibrosis Idiopathic pulmonary fibrosis is a diffuse interstitial lung disease of unknown etiology characterized by chronic inflammation and progressive fibrosis and carries a 3-year, 50% mortality. Currently, there are no eff See details	National Institutes of Health	5/08/2009
EMORY UNIVERSITY	$155,000	Trans-NIH Recovery Act Research Support Impact of Video Viewing on Infant Learning: Using Baby Signs as an Experimental Approach The American Academy of Pediatrics recommends that children under two refrain from watching television or videos on the grounds that infant viewing is potentially h See details	National Institutes of Health	5/08/2009
EMORY UNIVERSITY	$155,000	Trans-NIH Recovery Act Research Support Dietary Inorganic Phosphate as a Target for Nutritional Intervention in Cancer It is becoming increasingly apparent that diet can have profound effects on functional genomics. However, this area of research has only begun to be exploited for therapeutic b See details	National Institutes of Health	7/20/2009
EMORY UNIVERSITY	$155,000	Trans-NIH Recovery Act Research Support AWARD TITLE : INNATE IMMUNITY AND SIV INFECTION The primary objective of the studies proposed herein is to obtain sufficient preliminary data that can serve as a foundation for the formulation of hypothesis based questions as part of a regular RO1 applica See details	National Institutes of Health	5/10/2010
EMORY UNIVERSITY	$154,813	Trans-NIH Recovery Act Research Support General Magnitude Representation in Infancy: Testing the Associations among Space, Number, and Time Abstract: Space, number, and time provide fundamental sources of information by which we (and other animals) structure experience in the world. Althoug See details	National Institutes of Health	9/01/2009
EMORY UNIVERSITY	$154,463	Trans-NIH Recovery Act Research Support BASES OF PATHOPHYSIOLOGY IN GALACTOSEMIA Profound impairment of galactose-1-phosphate uridylyltransferase (GALT) results in the inborn error of metabolism classic galactosemia. Although the acute and potentially lethal sequelae of this disorder can be res See details	National Institutes of Health	1/30/2010
EMORY UNIVERSITY	$154,431	Trans-NIH Recovery Act Research Support In this research application, we seek to examine the topography of the corpus callosum (CC) at both the macrostructural and microstructural levels in primates. Comparative study of the primate CC is significant as this structure is believed to be fundame This spending item is part of a $485,591 allocation. See details	National Institutes of Health	3/15/2010
CNI INFORMATION TECHNOLOGY, LLC	$151,671	CYBER SECURITY SUPPORT FOR CDC See details	Centers for Disease Control and Prevention	12/18/2009
CNI INFORMATION TECHNOLOGY, LLC	$151,671	Planner Support for DHHS / See details	Centers for Disease Control and Prevention	12/18/2009
EMORY UNIVERSITY	$150,222	Trans-NIH Recovery Act Research Support The long-term objectives of this proposal are to understand the neurobiological basis of complex cognitive, perceptual and motor processes from the standpoint of neurophysiological and neuroanatomical specializations of the left and right cerebral hemisph This spending item is part of a $388,449 allocation. See details	National Institutes of Health	5/01/2010
EMORY UNIVERSITY	$150,000	Trans-NIH Recovery Act Research Support Efficacy and Mechanisms of GLN Dipeptide in the SICU (GLND trial): The purpose of this supplement is to accelerate the tempo of research in the current NIH/NIDDK-funded trial U01 DK069322 (the GLND study) by adding an additional study site at the Universi See details	National Institutes of Health	9/10/2009
EMORY UNIVERSITY	$150,000	Trans-NIH Recovery Act Research Support As part of the NCI Centers of Cancer Nanotechnology Excellence (CCNE) at Emory and Georgia Tech, we request supplemental support to accelerate the tempo in developing, standardizing, and scaling up two nanoparticle-based cancer drugs - one for targeting f This spending item is part of a $300,000 allocation. See details	National Institutes of Health	9/22/2009
EMORY UNIVERSITY	$149,977	The Cancer Knowledge Cloud will connect and share information generated through NCI genomic atlas projects, the caHUB tissue acquisition network, the NCI functional Biology Consortium, NCI patient Characterization Center, the NCI pre-clinical Development This spending item is part of a $103,000,000 allocation. See details	National Institutes of Health	11/23/2009
RFS Pharma, LLC	$149,333	Trans-NIH Recovery Act Research Support The Specific Aims of R01 AI071846 Rational Design of NRTI for Drug Resistant HIV-1 are to: (1)synthesize novel base modified 3'-azido-2',3'-dideoxypurines (ADPs) and to systematically identify the most potent compounds using a multi-disciplinary approach This spending item is part of a $486,282 allocation. See details	National Institutes of Health	5/24/2010
EMORY UNIVERSITY	$149,333	Trans-NIH Recovery Act Research Support The Specific Aims of R01 AI071846 Rational Design of NRTI for Drug Resistant HIV-1 are to: (1)synthesize novel base modified 3'-azido-2',3'-dideoxypurines (ADPs) and to systematically identify the most potent compounds using a multi-disciplinary approach This spending item is part of a $486,282 allocation. See details	National Institutes of Health	5/24/2010
EMORY UNIVERSITY	$140,401	Trans-NIH Recovery Act Research Support The collaborative clinical translational research (CTR) and career development program creates a model for senior residents and junior faculty who are interested in pursuing clinical and translational research as part of a competitive research-intensive s This spending item is part of a $215,516 allocation. See details	National Institutes of Health	12/09/2009
LOGISTICS HEALTH, INC.	$140,148	Provide a specialized Healthcare professional in the assessment and develop of State Public Healthcare standards and training. This spending item is part of a $212,413 allocation. See details	Centers for Disease Control and Prevention	10/21/2009
EXECUTIVE TECHNOLOGY, INC.	$140,083	Dell PowerEdge R910 Servers See details	Centers for Disease Control and Prevention	8/23/2010
LOGISTICS HEALTH, INC.	$140,070	Provide a specialized Lab Assistant in the Gastroenteritis Virus Program of DVD. See details	Centers for Disease Control and Prevention	9/28/2009
EMORY UNIVERSITY	$139,709	Trans-NIH Recovery Act Research Support TYPHOON PHOSPHORIMAGER. This is an instrumentation grant. This proposal seeks to obtain funds to purchase a Typhoon Trio Imager. Such imagers allow the capture, image construction, quantitative analyses, and production of publication images from numerous See details	National Institutes of Health	2/18/2010
BLUE TECH INC.	$137,895	Delivery of Dell servers, avocent switches,cisco switches. See details	Centers for Disease Control and Prevention	5/24/2010
EMORY UNIVERSITY	$135,625	Trans-NIH Recovery Act Research Support Title: Supplement to Functional approach to communication sound processing in mouse auditory cortex Early views of the adult auditory system describe it as a static processor of sound. Ample evidence now demonstrates though that the adult auditory syste See details	National Institutes of Health	7/17/2009
MERIDIAN EDUCATIONAL RESOURCE GROUP INC	$131,151	ARRA Health Center Integrated Services Development Initiative[g1] Increased Service for Health Center by retaining a Nurse Practitioner position. See details	Health Resources and Services Administration	3/27/2009
MERIDIAN EDUCATION RESOURCE GROUP, INC.	$131,151	ARRA Health Center Integrated Services Development Initiative[g1] Grant Name - Increased Demand for Service. Purpose - To retain a Nurse Practioner Position. Goals - To serve primarily uninsured and under insured patients whose number has increased due to the downturn in the economy in our area. Impoportance of achieving ... Show more See details	Health Resources and Services Administration	3/27/2009
EMORY UNIVERSITY	$124,269	Trans-NIH Recovery Act Research Support PepT1 is mainly expressed in brush-border membranes of enterocytes in the small intestine. PepT1 has a differential pattern of expression in the small intestine. Along the vertical axis, PepT1 is most abundant at the villous tip, with expression decreasin See details	National Institutes of Health	7/19/2010
GENETAG TECHNOLOGY INC	$124,025	Trans-NIH Recovery Act Research Support universal qPCR probes for influenza,supplement See details	National Institutes of Health	9/11/2009
MERLIN INTERNATIONAL, INC.	$123,593	Maintenance support for Agiliance products See details	Centers for Disease Control and Prevention	9/08/2010
VIRTUALLY BETTER INC	$122,708	Trans-NIH Recovery Act Research Support Children undergo many medical procedures that are anxiety provoking and painful. Research is accumulating to suggest that there are not only immediate but also delayed repercussions to untreated pediatric pain. Parents and medical personnel experience co This spending item is part of a $522,955 allocation. See details	National Institutes of Health	9/29/2009
EMORY UNIVERSITY	$116,250	Trans-NIH Recovery Act Research Support Emory Parkinson's Disease Environmental Research Center (PD-CERC) Supplement 2: New transgenic mouse lines Recent advances by investigators in the PD-CERC highlight the need for the production of two new mouse models to better understand environmental inf See details	National Institutes of Health	7/02/2010
EMORY UNIVERSITY	$114,575	The Cancer Knowledge Cloud will connect and share information generated through NCI genomic atlas projects, the caHUB tissue acquisition network, the NCI functional Biology Consortium, NCI patient Characterization Center, the NCI pre-clinical Development This spending item is part of a $103,000,000 allocation. See details	National Institutes of Health	11/23/2009
EMORY UNIVERSITY	$114,413	Trans-NIH Recovery Act Research Support Steroid hormone receptors play key roles in cancer as well as numerous other diseases and conditions affecting metabolism, immunity, and reproduction. Evolutionary studies are a powerful means to characterize protein structure-function relations, the fund This spending item is part of a $209,413 allocation. See details	National Institutes of Health	2/05/2010
EMORY UNIVERSITY	$113,500	The purpose of this task order is to support various VRC Universal Influenza studies. Specifically,the EMMES Corporation will provide all necessary technical, clinical, and management services in order to support four phase-I clinical trials (2 adult,2 pe This spending item is part of a $8,654,779 allocation. See details	National Institutes of Health	9/30/2010
EMORY UNIVERSITY	$112,083	Trans-NIH Recovery Act Research Support As new technologies such as virtual microscopes, multi-spectral imaging, and antibody-conjugated quantum dot probes (QD) continue to gain acceptance we have capitalized on the modular, flexible design of the imaging tools that we are developing so that wi This spending item is part of a $249,239 allocation. See details	National Institutes of Health	9/30/2009
EMORY UNIVERSITY	$110,085	Trans-NIH Recovery Act Research Support Title of the award is Administrative Supplements for HALT Polycystic Kidney Disease Clinical Trial Network. The specific aims of the work to be supported by the requested administrative supplement will accelerate and expand the work plan contemplated unde See details	National Institutes of Health	9/21/2009
EMORY UNIVERSITY	$109,620	Trans-NIH Recovery Act Research Support ADMIN SUPPLEMENT - HER-2/IGF-IR CROSSTALK AND HERCEPTIN The her2 gene is overexpressed in approximately 30% of metastatic breast cancers, and is associated with rapid disease progression and poor survival. Herceptin, a recombinant humanized anti-HER2 mon See details	National Institutes of Health	9/15/2009
EMORY UNIVERSITY	$108,000	Trans-NIH Recovery Act Research Support Pro-Apoptotic Therapeutics with Kinase Inhibition in Neuroblastoma Neuroblastoma (NB) is a highly lethal solid tumor of childhood. Most patients eventually die of their disease due in part to the tumor's inability to die by programmed cell death leading t See details	National Institutes of Health	9/29/2009
EMORY UNIVERSITY	$107,689	Trans-NIH Recovery Act Research Support The Epilepsy Phenome/Genome Project is investigating how genes influence the phenotypes of common and rare epilepsies and has proposed to accelerate collection of phenotypic information by hiring a research assistant at each clinical center. This spending item is part of a $1,558,189 allocation. See details	National Institutes of Health	9/25/2009
EMORY UNIVERSITY	$107,042	Trans-NIH Recovery Act Research Support Fostering Global Health Opportunities fro Emory and Its Partners Incorporating state of the art information and communication technologies (ICT) into Framework educational programs and activities is critical if Emory University is to remain among the lead See details	National Institutes of Health	9/03/2009
EMORY UNIVERSITY	$106,821	Trans-NIH Recovery Act Research Support Title: Nitrated Fatty Acids, Novel Anti-inflammatory Mediators in Allergic Airway Disease Asthma is a highly prevalent airway disease for which available treatment options are inadequate. Endogenous nitrated fatty acids (NFAs), produced from NO, have rece See details	National Institutes of Health	8/30/2010
EMORY UNIVERSITY	$106,202	Trans-NIH Recovery Act Research Support Title: 'Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients' - This is a two-year planning grant for a future multi-center, randomized clinical trial assessing the efficacy and safety of immunosuppression withdrawal for stable pe This spending item is part of a $888,643 allocation. See details	National Institutes of Health	9/29/2009
EMORY UNIVERSITY	$105,284	Trans-NIH Recovery Act Research Support A Novel Approach for Diagnosis and Newborn Screening for 22Q11 Deletion Syndrome Research Plan for supplement: The requested administrative supplement for this proposal will increase the hours of current staff to maintain them at a full-time position and See details	National Institutes of Health	9/21/2009
EMORY UNIVERSITY	$103,408	Trans-NIH Recovery Act Research Support The goal of this project is to increase recruitment and retention of underrepresented and underserved populations into AIDS Clinical Trials Group (ACTG) clinical trials. The ACTG is committed to enrollment of domestic clinical trial participants in propor This spending item is part of a $1,130,883 allocation. See details	National Institutes of Health	9/21/2009
EMORY UNIVERSITY	$103,100	Trans-NIH Recovery Act Research Support Title of grant: Regulation of pendrin by angiotensin II With this supplemental funding we are exploring the role of T and B lymphocytes in the regulation of pendrin by angiotensin II. Thus, we have been able to retain the services of Mr. Seongun Hong. Mor See details	National Institutes of Health	12/08/2009
EMORY UNIVERSITY	$103,015	Trans-NIH Recovery Act Research Support Purpose:The BCM-Emory Fragile X research center ARRA stimulus funds requested here will accelerate efforts to understand and treat these disorders through the study of patient symptoms and models of the diseases. Abstract: The BCM-Emory Fragile X Researc This spending item is part of a $399,941 allocation. See details	National Institutes of Health	9/16/2009
EMORY UNIVERSITY	$101,600	Trans-NIH Recovery Act Research Support 1. Purchase equipment to aid in purification of flagellin and analysis of TLR5-deficient mice. 2. Utilize a commercial provider to generate TLR5 in a gnotobiotic state. This will generate employment opportunities at Taconic, Inc (Taconic, NY). The mice ha See details	National Institutes of Health	1/19/2010
STAND, INC.	$101,000	Trans-NIH Recovery Act Research Support The purpose of this award of American Recovery and Reinvestment Act (ARRA) funds is to accelerate the tempo of scientific research at the Emory HIV/AIDS Clinical Trials Unit (EHCTU). The ARRA funds are requested specifically to accelerate the research bei This spending item is part of a $4,827,520 allocation. See details	National Institutes of Health	9/01/2009
EMORY UNIVERSITY	$100,392	Trans-NIH Recovery Act Research Support Ultrasonic Tissue-Typing-Guided Prostate Brachytherapy. The purpose of this supplemental proposal is to increase the target number of patients in our clinical study by 40% (from 100 to 140), strengthening the statistical power of our parent grant. In ad See details	National Institutes of Health	9/14/2009
EMORY UNIVERSITY	$100,001	Trans-NIH Recovery Act Research Support Urea plays an important role in the urinary concentrating mechanisms. In the past decade, significant progress has been made in understanding urea reabsorption and recycling in kidney mediated by two facilitated urea transporter genes, UT-A and UT-B. Howe See details	National Institutes of Health	12/07/2009
EMORY UNIVERSITY	$100,001	Trans-NIH Recovery Act Research Support REGULATION OF SODIUM IN TIGHT EPITHELIA. This award is an administrative supplement to R37 DK037963 G?Regulation of Sodium Transport in Tight EpitheliaG?. The parent grant is in the third year of a five year extension of a Merit Award. The aims of the ori See details	National Institutes of Health	12/07/2009
EMORY UNIVERSITY	$100,000	Trans-NIH Recovery Act Research Support REGULATION OF RAT RENAL INNER MEDULLARY FUNCTION. The major goal of the parent grant, 5R01DK041707, is to test two hypotheses: 1?? vasopressin rapidly increases UT-A1 accumulation in the apical plasma membrane; and 2?? vasopressin regulates UT-A1 retrieva See details	National Institutes of Health	8/20/2009
EMORY UNIVERSITY	$100,000	Trans-NIH Recovery Act Research Support This is a request for an Administrative Supplement to parent grant R01 DK050740 entitled G?Muscle-specific nutritional adaptations to catabolic statesG? which is funded through 7/31/10. The aims of the grant are: 1) to study how FOXO1 and FOXO3a affect sk See details	National Institutes of Health	12/07/2009
EMORY UNIVERSITY	$99,984	Trans-NIH Recovery Act Research Support A C.elegans model for EPEC & EHEC Pathogenesis. The project is designed to understand evolutionarily conserved mechanisms by which the immune system detects pathogens. Here we use the model genetically maleable nematode Cenorhabditis elegans to determine See details	National Institutes of Health	9/29/2009
EMORY UNIVERSITY	$99,906	Trans-NIH Recovery Act Research Support Acute flares of inflammatory diseases of the intestine are characterized by the migration of neutrophils across the intestinal epithelium into the lumen to form 'crypt abscess'. Adenosine is generated during active intestinal inflammation by the conversio See details	National Institutes of Health	9/16/2009
EMORY UNIVERSITY	$99,901	Trans-NIH Recovery Act Research Support This supplemental request encompasses activities of the Emory Epithelial Pathobiology Research Development Center core facilities and will update and add to essential components of the Morphology/Image Analysis Core (Core B) and Cell Culture and Monoclona See details	National Institutes of Health	7/21/2009
EMORY UNIVERSITY	$99,820	Trans-NIH Recovery Act Research Support The parent project entitled The Role of Leptin in Liver Fibrogenesis was competetively renewed on April 1, 2008 for four years. This application was funded via the R01 investigator-initiated mechanism for four years. The central hypothesis of the parent g See details	National Institutes of Health	9/01/2009
EMORY UNIVERSITY	$99,002	Trans-NIH Recovery Act Research Support Our long-term goal of the parent grant is to understand the cellular signaling mechanisms in intestinal epithelia with an emphasis on how protein-protein interaction affects the specificity and efficiency of signaling processes. Lysophosphatidic acid (LPA See details	National Institutes of Health	9/16/2009
EMORY UNIVERSITY	$98,678	Trans-NIH Recovery Act Research Support HISTONE LYSINE METHYLATION: STRUCTURES AND FUNCTIO The new equipment will accelerate progress in the funded project G?? 2R01GM068680-06. The project focuses on epigenetic regulation, a newly appreciated and fundamentally important set of gene control mech See details	National Institutes of Health	8/30/2010
EMORY UNIVERSITY	$97,803	Trans-NIH Recovery Act Research Support Most HIV transmissions occur mucosally, including mother-to-child transmission (MTCT). As HIV clade C predominates worldwide, we initially focused on immunoprevention of HIV clade C MTCT. We identified a quadruple (4x) combination of human neutralizing mo This spending item is part of a $1,974,218 allocation. See details	National Institutes of Health	9/01/2009
EMORY UNIVERSITY	$97,684	Trans-NIH Recovery Act Research Support CTL ESCAPE AND REVERSION IN LINKED PAIRS Recent studies have demonstrated that HIV immune escape follows a predictable mutational path in response to an individualG??s genetic environment, specifically an individualG??s HLA alleles. Since immune escape f See details	National Institutes of Health	7/23/2009
EMORY UNIVERSITY	$97,439	Trans-NIH Recovery Act Research Support DNA Methylation: Structures, Functions, and regulation The major goal of this project is to continue the investigation of functional role of posttranslational modifications of mammalian DNA methyltransferases (Dnmts) in epigenetic regulation of gene expre See details	National Institutes of Health	9/30/2010
EMORY UNIVERSITY	$94,006	Trans-NIH Recovery Act Research Support We are proposing a predoctoral training program in Biostatistics in Genetics, Immunology, and Neuroimaging (BGIN). In this program, students will learn to develop statistical and computational innovations applied in one of three areas of concentration: 1. See details	National Institutes of Health	8/03/2009
EMORY UNIVERSITY	$92,806	The Systolic Blood Pressure Intervention Trial (SPRINT)-Senior ARRA expansion is designed to test the SPRINT intervention in participants who are ? 75 years of age. Approximately 3,250 of the 9,250 SPRINT participants are expected to be age 75 or older. I This spending item is part of a $2,671,616 allocation. See details	National Institutes of Health	9/24/2010
BLUE TECH INC.	$92,445	Delivery of mandiant software and appliance See details	Centers for Disease Control and Prevention	8/24/2010
EMORY UNIVERSITY	$89,745	Trans-NIH Recovery Act Research Support This funding has purchased a state of the art rapid scan stopped flow spectrometer for use in biochemical research on the structure and function of the human enzymes Monoamine Oxidase A and Monoamine Oxidase B. These enzyme are know to be elevated in the See details	National Institutes of Health	9/30/2009
INNERFACE ARCHITECTURAL SIGNAGE, INC.	$82,978	Whiteriver IH Signage This spending item is part of a $149,996 allocation. See details	Indian Health Service	9/25/2009
EMORY UNIVERSITY	$82,339	Trans-NIH Recovery Act Research Support The elongation of transcripts by RNA polymerase II is a complex process dependent upon nucleotide substrate levels, elongation factors, and co-transcriptional events such as splicing. Mutations in genes encoding elongation factor SI I (TFIIS), other elong See details	National Institutes of Health	9/09/2009
EMORY UNIVERSITY	$81,403	Trans-NIH Recovery Act Research Support Increases in childhood obesity are a public health concern worldwide. In the U.S., 17.6 percent of adolescents have high BMIs for their age. Obesity early in life is associated with poorer physical and mental health and social wellbeing, including respira This spending item is part of a $164,250 allocation. See details	National Institutes of Health	7/16/2009
EMORY UNIVERSITY	$81,403	Trans-NIH Recovery Act Research Support Increases in childhood obesity are a public health concern worldwide. In the U.S., 17.6 percent of adolescents have high BMIs for their age. Obesity early in life is associated with poorer physical and mental health and social wellbeing, including respira This spending item is part of a $164,250 allocation. See details	National Institutes of Health	7/16/2009
EMORY UNIVERSITY	$81,355	Trans-NIH Recovery Act Research Support The Na+/H+ exchanger isoform 3 (NHE3) constitutes a major Na+ transport process, which moves a large quantity of salt and water from the mucosal side toward the serosal side. Our long-term goal is to understand the molecular mechanisms that control NHE3 a See details	National Institutes of Health	8/31/2009
EMORY UNIVERSITY	$79,332	Trans-NIH Recovery Act Research Support The mammalian intestinal epithelium is a dynamic system in which cell proliferation is closely linked to differentiation and cell death. Studies have identified several important pathways such as Wnt, Notch, BMP and hedgehog that are involved in maintaini See details	National Institutes of Health	8/17/2009
EMORY UNIVERSITY	$77,500	Trans-NIH Recovery Act Research Support The pathogenesis of sickle cell nephropathy. Sickle cell nephropathy is a common complication of sickle cell disease that affects both children and adults, and may lead to kidney failure. The mechanisms that cause kidney damage in sickle cell disease are See details	National Institutes of Health	1/01/2010
EMORY UNIVERSITY	$77,449	Trans-NIH Recovery Act Research Support Emory Parkinson's Disease Environmental Research Center (PD-CERC) Supplement 1: Identification of compounds that enhance vesicular storage of dopamine and other monoamines The vesicular monoamine transporter 2 (VMAT2) in monoamine neurons (nerve cells) pa See details	National Institutes of Health	7/01/2010
EMORY UNIVERSITY	$76,771	Trans-NIH Recovery Act Research Support Each year, approximately five million people die from injuries, and millions more develop temporary or permanent disability, exacting a profound toll on the individual, family and society. Injury places a significant burden on countries with limited resou See details	National Institutes of Health	9/03/2009
SCIMETRIKA, LLC	$76,238	Improvement of laboratory based detection and characterization of bacterial agents of vaccine preventable diseases including pertussis and meningitis in public health laboratories in the US. This spending item is part of a $314,149 allocation. See details	Centers for Disease Control and Prevention	9/24/2009
EMORY UNIVERSITY	$74,805	Trans-NIH Recovery Act Research Support Although state and local mandatory helmet laws have become widespread in the US, there is almost no information on whether such regulations actually decrease injuries from bicycle-related accidents. The first aim is to use pooled, annual, hospital-level d This spending item is part of a $166,064 allocation. See details	National Institutes of Health	5/21/2009
EMORY UNIVERSITY	$73,510	Trans-NIH Recovery Act Research Support The overall objective of this U54 application is to characterize, at molecular and cellular levels, the hormonal pathways that regulate embryo implantation and fertility. Failure of the fertilized embryo to implant into the endometrium is a major cause o This spending item is part of a $282,602 allocation. See details	National Institutes of Health	9/28/2009
EMORY UNIVERSITY	$73,486	Trans-NIH Recovery Act Research Support The award title is Cosmc - A Novel Molecular Chaperone Regulating O-Glycans.? This supplemental funding has helped to promote our work on a unique protein Cosmc, which is involved in several human disorders. The funds here helped us retain and fund the wo See details	National Institutes of Health	9/30/2009
BOOZ ALLEN HAMILTON INC.	$72,265	Provide a specialized Healthcare professional in the assessment and develop of State Public Healthcare standards and training. This spending item is part of a $212,413 allocation. See details	Centers for Disease Control and Prevention	10/21/2009
EMORY UNIVERSITY	$71,774	Trans-NIH Recovery Act Research Support Severe traumatic injuries and invasive surgical procedures such as tumor resection often create peripheral nerve gaps, accounting for 200,000 injuries in the US annually. The clinical gold standard for bridging peripheral nerve gaps is autografts (typical This spending item is part of a $764,733 allocation. See details	National Institutes of Health	7/15/2009
EMORY UNIVERSITY	$71,522	Trans-NIH Recovery Act Research Support Good glycemic control, lipid control, or blood pressure (BP) control can be achieved by adherence to recommended care, including medication, preventive care, and lifestyle modifications. Good physiologic control, in turn, attenuates risk of progression to This spending item is part of a $339,604 allocation. See details	National Institutes of Health	8/04/2009
EMORY UNIVERSITY	$70,201	ARRA - Public Health Traineeship Program The program objectives address USPHS priority for Healthy People 2010, Focus Area 23, Building the public health infrastructure. The program recruits and trains students to serve in defined shortage areas of epidemiology, environmental health and biostat See details	Health Resources and Services Administration	9/03/2009
EMORY UNIVERSITY	$68,541	Trans-NIH Recovery Act Research Support Title: Administrative supplement for pyrophosphate in vascular calcification of renal failure. Pyrophosphate (PPi) is a potent endogenous inhibitor of vascular calcification. The purpose of the project is to apply new techniques , specifically geneti See details	National Institutes of Health	9/07/2009
EMORY UNIVERSITY	$65,947	Trans-NIH Recovery Act Research Support ADMINISTRATIVE SUPPLEMENT FOR ENHANCING THE EFFECTIVENES OF A CULTURALLY SENSITIVE ORGAN DONATION INTERVENTION This Phase II randomized effectiveness trial utilizes a 2x2 simple factorial design with four conditions: (a) Enhanced DVD shown in a group sett See details	National Institutes of Health	9/21/2009
EMORY UNIVERSITY	$64,950	Trans-NIH Recovery Act Research Support Functional Substructure of Flagellar Dynein (3R37GM051173-25S1) This award is an Administrative Supplement from the NIGMS to support our research on cilia and the ciliary dyneins. Based on several advances, the significance of our work on cilia has been g See details	National Institutes of Health	9/30/2009
EMORY UNIVERSITY	$64,001	Trans-NIH Recovery Act Research Support Parent Grant Title: Cellular Targets of Polyomavirus Transforming Proteins The expertise my laboratory has developed and the many reagents we have created have placed us in an outstanding position to help elucidate the roles and regulation of the enzyme, See details	National Institutes of Health	8/27/2009
EMORY UNIVERSITY	$61,738	Trans-NIH Recovery Act Research Support Cellular Responses to Radiation and Other Types of Damage Radiation is responsible for mutation and genomic instability as a result of DNA strand nicks and breaks and misreplication of damaged DNA. This damage if not correctly repaired is responsible for See details	National Institutes of Health	9/09/2009
EMORY UNIVERSITY	$60,000	Trans-NIH Recovery Act Research Support The cell's ability to sense the environment and to determine the direction and proximity of an extracellular stimulus, followed by correct movement, is fundamental not only for brain development but also for immunity, angiogenesis, wound healing, and embr See details	National Institutes of Health	9/30/2009
EMORY UNIVERSITY	$59,454	Trans-NIH Recovery Act Research Support This supplement develops a new collaboration between Dr. Craig Coopersmith (PI, parent grant) and Dr. Nicholas Davidson, Professor of Medicine, Director Division of Gastroenterology Washington University. Dr. CoopersmithG??s research focuses on understand This spending item is part of a $102,326 allocation. See details	National Institutes of Health	9/01/2010
EMORY UNIVERSITY	$59,237	Trans-NIH Recovery Act Research Support This application addresses the broad Challenge Area (05) Comparative Effectiveness Research and specific Challenge Topic, 05-GM-101: Anesthesiology Clinical Pharmacology Sepsis Trauma, Burn, and Peri-operative Injury Wound Healing. Traumatic brain injury This spending item is part of a $980,750 allocation. See details	National Institutes of Health	9/30/2009
EMORY UNIVERSITY	$59,178	Trans-NIH Recovery Act Research Support Effects of mGluR2/3 Activation on Cue-Induced Cocaine Relapse in Squirrel Monkeys Despite substantial efforts, there are currently no FDA-approved pharmacotherapies available for the treatment of cocaine abuse or dependence. A prominent feature of cocain See details	National Institutes of Health	5/07/2009
EMORY UNIVERSITY	$58,452	Trans-NIH Recovery Act Research Support My award title is HIV-INDUCED 5-LIPOXYGENASE: ROLE IN HIV-RELATED PULMONARY ATERIAL HYPERTENSION. My research aim is to determine whether HIV-1 increases the susceptibility of infected individuals to develop the non-infectious pulmonary vasculature disord See details	National Institutes of Health	7/17/2009
EMORY UNIVERSITY	$57,656	Trans-NIH Recovery Act Research Support Drugs targeting the HIV virus transcriptase or protease are used in highly active antiretroviral therapy (HAART) cocktails that have prolonged the lives of AIDS patients. Unfortunately, these drugs are associated with severe toxicities, unable to control This spending item is part of a $427,955 allocation. See details	National Institutes of Health	9/01/2009
EMORY UNIVERSITY	$55,133	Trans-NIH Recovery Act Research Support This study seeks to elucidate the mechanistic basis of immune responses to factor VIII (FVIII) in some but not all hemophilia A (HA) patients and the increased risk of HA patients with black African ancestry for developing that complication following ther This spending item is part of a $6,507,463 allocation. See details	National Institutes of Health	9/24/2009
EMORY UNIVERSITY	$54,403	Trans-NIH Recovery Act Research Support Even though major advances have been made in the past decade with respect to understanding the genetics, environmental and immune dysregulation in IBD, the etiopathogenesis of IBD is poorly understood. It is envisaged that this investigation will define t See details	National Institutes of Health	9/22/2009
EMORY UNIVERSITY	$54,170	Trans-NIH Recovery Act Research Support Ethically-engaged research requires a commitment to universal ethical norms, such as those expressed in the Declaration of Helsinki and the Belmont Report, tempered by a recognition that their implementation and the relative weight given to competing ethi See details	National Institutes of Health	9/25/2010
EMORY UNIVERSITY	$54,000	Trans-NIH Recovery Act Research Support PROLIFERATIVE RESPONSES TO ENTERIC PATHOGENS IN INTESTINAL TISSUES Funding for the K01 parent grant was provided to study the protein Kruppel-like factor 5 (KLF5), a protein that promotes cell division/proliferation in the intestines. Preliminary evidenc See details	National Institutes of Health	8/14/2009
EMORY UNIVERSITY	$54,000	Trans-NIH Recovery Act Research Support The parent grant, 1K01DK082733-01, aimed to determine if a vasopressin-mediated increase in intracellular cAMP would stimulate a specific signaling complex of proteins that regulate UT-A1 function. The above hypothesis will be resolved by: 1. Determining See details	National Institutes of Health	12/17/2009
EMORY UNIVERSITY	$54,000	Trans-NIH Recovery Act Research Support REGULATION OF SODIUM CHLORIDE COTRANSPORTER BY WNK KINASE WNK (with no lysine (k)) is one of the new family of serine/thereonine kinases. Mutation in two members of this kinase, WNK1 and WNK4, causes pseudohypoaldosteronism type II (PHA II). The emerged e See details	National Institutes of Health	1/08/2010
EMORY UNIVERSITY	$54,000	Trans-NIH Recovery Act Research Support Mechanisms of Tenofovir Renal Tubular Toxicity The project defines TDF renal tubular transport and mitochondrial biogenesis in TDF nephrotoxicity. Renal tubular toxicity from TDF is a recongnized side effect with incompletely understood mechanisms. The pr See details	National Institutes of Health	1/06/2010
MERLIN INTERNATIONAL, INC.	$53,410	Juniper products and Maintenance See details	Centers for Disease Control and Prevention	7/26/2010
EMORY UNIVERSITY	$53,320	Trans-NIH Recovery Act Research Support Regulation of the Sodium chloride Cotransporter: The purpose of the funding is to investigate the regulation of this important effector of blood pressure control by kinases and second messengers. The Sodium Chloride Cotransporter is the site of action of See details	National Institutes of Health	1/28/2011
EMORY UNIVERSITY	$52,313	Trans-NIH Recovery Act Research Support The Prenatal Cytogenetic Diagnosis by Array-Based Copy Number Analysis (aCNA) administrative supplement has goals consistent with ARRA funding guidelines. The supplement will: 1) create new geographically dispersed jobs for the entire 2 year period, 2) a This spending item is part of a $744,988 allocation. See details	National Institutes of Health	9/29/2009
EMORY UNIVERSITY	$50,440	Trans-NIH Recovery Act Research Support The overall objective of the above proposal on which we base this administrative supplement is to characterize the role of metalloproteinase-9 (MMP-9) in intestinal epithelial cell differentiation and wound healing. The major GOAL of the Administrative Su See details	National Institutes of Health	2/23/2010
MERLIN INTERNATIONAL, INC.	$50,250	Agiliance-Merlin Web Services and Risk assessment reporting See details	Centers for Disease Control and Prevention	8/17/2010
EMORY UNIVERSITY	$50,000	Trans-NIH Recovery Act Research Support This award is an administrative supplement for a Career Transition Award from the Center to Reduce Cancer Health Disparities at NCI to promote the advancement of minority scientist towards independence and research on health disparities related issues. Th See details	National Institutes of Health	9/28/2009
EMORY UNIVERSITY	$50,000	Trans-NIH Recovery Act Research Support ADOPTion of New Technologies for Remote Data Capture and Protocol Authoring (ADOPT) The NCI has made significant progress in reconfiguring the NCI trials infrastructure to allow investigators to take full advantage of scientific opportunities. In order fo See details	National Institutes of Health	9/29/2009
EMORY UNIVERSITY	$49,945	Trans-NIH Recovery Act Research Support This administrative supplement application encompasses activities of the Emory Epithelial Pathobiology Research Development Center and is aimed at updating a critical component of the Morphology and Image Analysis Core (Core B). Research supported by the See details	National Institutes of Health	1/18/2010
EMORY UNIVERSITY	$49,338	Trans-NIH Recovery Act Research Support TITLE: Role of Syk and Rac2 in regulation of HIF1alpha and neovascularization Postnatal neovascularization plays a critical role in pathogenesis of numerous diseases e.g. diabetic retinopathy, tissue remodeling upon injury, rheumatoid arthritis and tumor See details	National Institutes of Health	5/15/2009
CORE-SDI INC	$49,140	Core Impact 2 Machine license for 1 Year See details	Centers for Disease Control and Prevention	9/09/2010
EMORY UNIVERSITY	$49,104	Trans-NIH Recovery Act Research Support Unwanted childbearing has been hypothesized to have significant detrimental health, social and economic consequences for children and parents, and represents a primary justification for investment in family planning programs. While the literature supporti This spending item is part of a $176,840 allocation. See details	National Institutes of Health	5/21/2009
SCIMETRIKA, LLC	$46,885	The work performed will support the implementation of immunization activities funded through ARRA, including reaching more children and adults with immunization; enhancing information, education and communications about immunization; and strengthening the This spending item is part of a $218,209 allocation. See details	Centers for Disease Control and Prevention	9/24/2009
EMORY UNIVERSITY	$45,999	Trans-NIH Recovery Act Research Support This supplemental award supports the Accelerating Clinical Trials of Novel Oncologic Path Ways (ACTNOW) program for Protocol ANBL0931, which is a Phase III Study of Chimeric Antibody 14.18 in High-Risk Neuroblastoma. The primary objective of study ANBL09 This spending item is part of a $1,981,588 allocation. See details	National Institutes of Health	8/07/2009
EMORY UNIVERSITY	$45,910	Trans-NIH Recovery Act Research Support This administrative supplement application is submitted in response to NIH ARRA request for applications, and is part of the G?Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD)G?. One of the overall goals of the entire CIFASD is to det This spending item is part of a $64,956 allocation. See details	National Institutes of Health	9/03/2010
EMORY UNIVERSITY	$45,138	Trans-NIH Recovery Act Research Support The title of this award is Spinal Circuits and the Musculoskeletal System. The goal of this research is to evaluate the effects of interventions aimed at restoration of function following injuries to peripheral nerves. Such injuries occur commonly and are This spending item is part of a $169,225 allocation. See details	National Institutes of Health	8/25/2010
CNI INFORMATION TECHNOLOGY, LLC	$44,512	Cyber Security Support for DHHS Incident Response Expert (THIS REPORT REFLECTS THE CUMMULATIVE INVOICED AMOUNTS SINCE THE START OF PERFOMANCE ON THE TASK) See details	Centers for Disease Control and Prevention	2/02/2010
EMORY UNIVERSITY	$43,358	Trans-NIH Recovery Act Research Support Currently, the most accurate experiment approach to quantitatively measure gap junction mediated biochemical coupling is the LAMP assay. The LAMP method is noninvasive and offers excellent temporal resolution. The dyes used in LAMP have high ultraviolet ( See details	National Institutes of Health	7/21/2009
DEKALB, COUNTY OF	$40,815	ARRA - Immunization Georgia Immunization Program used ARRA funding to increase vaccine availability and services to adults and adolescents and increase the capacity of for data collection for Public Health Immunization data systems. The Georgia WIC program serves approximat This spending item is part of a $1,850,152 allocation. See details	Centers for Disease Control and Prevention	9/28/2009
EMORY UNIVERSITY	$39,057	Trans-NIH Recovery Act Research Support Award Title: Gonococci: Genetics of Resistance to PMN Proteins (25S1): The development of antimicrobial resistance in the Gram-negative strict human pathogen Neisseria gonorrhoeae is a growing public health problem. The current CDC guideline states that c See details	National Institutes of Health	9/20/2010
ARETE GOVERNMENT SOLUTIONS, LLC	$38,036	The Centers for Disease Control have a Centers-wide requirement for transportable USB storage devices which will significantly increase CDC personnel productivity. CDC personnel will be able to access data stored on these devices wherever they may be. Gov This spending item is part of a $1,108,207 allocation. See details	Centers for Disease Control and Prevention	12/17/2009
EMORY UNIVERSITY	$37,975	Trans-NIH Recovery Act Research Support STRUCTURE FUNCTION STUDIES ON INTESTINAL EPITHELIAL JAM Our proposed studies encompass detailed cell-biological approaches that have resulted in major advances in understanding the molecular basis of how JAM-A signals to regulate cell migration and perme See details	National Institutes of Health	8/14/2009
SWORD & SHIELD ENTERPRISE SECURITY, INC.	$37,835	Miscellaneous Dell computer equipment See details	Centers for Disease Control and Prevention	8/06/2010
SWORD & SHIELD ENTERPRISE SECURITY, INC.	$37,322	Miscellaneous Dell computer equipment See details	Centers for Disease Control and Prevention	9/29/2009
EMORY UNIVERSITY	$37,265	Trans-NIH Recovery Act Research Support This administrative supplement grant will provide a timely support for the structural characterization of a human DNA/RNA modification protein ABH3 bound to DNA. ABH3 is a human homologue of E. Coli AlkB. This protein has been identified as a prostate c This spending item is part of a $115,943 allocation. See details	National Institutes of Health	9/14/2009
RED RIVER COMPUTER CO., INC.	$36,753	TAS::75 0141::TAS RECOVERY ACT 00HCAJ1N-2010-80507 - ARRA RECOVERY ACT - DHHS CSIRC CONNECTRA See details	Centers for Disease Control and Prevention	3/25/2010
INNERFACE ARCHITECTURAL SIGNAGE, INC.	$36,150	SELLS-Repl Interior Signage This spending item is part of a $122,982 allocation. See details	Indian Health Service	5/11/2010
EMORY UNIVERSITY	$34,875	Trans-NIH Recovery Act Research Support This two-year study will utilize a randomized design with the active interventions running for 18 months. We have 26 active US sites (27 approved sites with one having to drop out due to lack of indirect cost recovery to pay IRB costs). The 26 sites will This spending item is part of a $1,349,862 allocation. See details	National Institutes of Health	8/19/2009
EMORY UNIVERSITY	$31,000	Trans-NIH Recovery Act Research Support This summer student research will support and accelerate aim-3 of the parent grant to identify the cause of exaggerated glutamate receptor signaling at synapses in a mouse model of fragile x syndrome. This research will provide students with training and See details	National Institutes of Health	6/01/2009
EMORY UNIVERSITY	$30,721	Trans-NIH Recovery Act Research Support The impact that drug addictions have on health disparities impacting at-risk African Americans who reside in the rural South are grossly understudied. While there is strong evidence linking drug use and abuse to violent behaviors, injuries, mental health, This spending item is part of a $471,683 allocation. See details	National Institutes of Health	8/31/2009
EMORY UNIVERSITY	$30,009	Trans-NIH Recovery Act Research Support This application addresses Broad Challenge Area (04) Clinical Research, and specific Challenge Topics, 04-NS-103 Developing consortia for clinical research, and is also, in part, relevant to 07-OD(ORDR)-102* Rare disease genetic patient registry. The Univ This spending item is part of a $1,000,000 allocation. See details	National Institutes of Health	9/28/2009
EMORY UNIVERSITY	$29,797	Trans-NIH Recovery Act Research Support Cellular Signaling and Kidney Function This supplemental funding application requests support for 4 undergraduate summer students for 2 years to participate in the research described in our program project grant P01-DK61521. This PPG is a joint endea See details	National Institutes of Health	7/13/2009
EMORY UNIVERSITY	$28,204	Trans-NIH Recovery Act Research Support Purpose: The study will determine the influence of genetic risk factors on radiotherapy sensitivity among childhood cancer survivors, using the existing Childhood Cancer Survivor Study (CCSS) cohort. The Childhood Cancer Survivor Study (CCSS) is a retros This spending item is part of a $410,944 allocation. See details	National Institutes of Health	7/16/2009
EMORY UNIVERSITY	$27,900	Trans-NIH Recovery Act Research Support Detection of Left Ventricular Dyssynchrony by Cross-Correclation Analysis The purpose of the funding was to create a position for a student to obtain research experience in the summer and fall of 2009. The funding allowed the student to perform added ana See details	National Institutes of Health	6/01/2009
INTELLIGENT DECISIONS, INC.	$27,662	Dell Computer Equipment See details	Centers for Disease Control and Prevention	8/25/2010
EMORY UNIVERSITY	$26,689	Trans-NIH Recovery Act Research Support The NBER Program Project on the Economics of Aging is a coordinated set of research projects on the health and economic circumstances of individuals as they age and on the implications of population aging. Its six major themes are: work and retirement be This spending item is part of a $2,189,997 allocation. See details	National Institutes of Health	4/20/2010
HABESHA, INC	$25,000	ARRA - Prevention and Wellness--State Territories and Pacific Islands The Georgia Department of Community Health, Division of Public Health, Healthy Communities Initiative focuses on implementing evidence-based policy and environmental changes to support and institutionalize healthy behaviors relateted to obesity, physical ac... Show more This spending item is part of a $1,268,574 allocation. See details	Centers for Disease Control and Prevention	2/04/2010
CENTER FOR PANASIAN COMMUNITY SERVICES INC	$25,000	ARRA - Prevention and Wellness--State Territories and Pacific Islands The Georgia Department of Community Health, Division of Public Health, Healthy Communities Initiative focuses on implementing evidence-based policy and environmental changes to support and institutionalize healthy behaviors relateted to obesity, physical ac... Show more This spending item is part of a $1,268,574 allocation. See details	Centers for Disease Control and Prevention	2/04/2010
AGNES SCOTT COLLEGE, INC.	$23,931	Trans-NIH Recovery Act Research Support The long-term objectives of the proposed studies are to understand the role that early environment plays in the development of asymmetries in manual gestures and facial expressions and their relationship to different structures of the brain. In the propos See details	National Institutes of Health	7/15/2009
CARAHSOFT TECHNOLOGY CORPORATION	$21,448	Delivery of various Vmware licenses and support to the recipient. See details	Health and Human Services, Department of	9/10/2010
COMPUTECH INTERNATIONAL, INC.	$17,048	APC UPS See details	Centers for Disease Control and Prevention	7/31/2010
DLT SOLUTIONS, LLC	$16,128	Quest Software and Maintenance This spending item is part of a $209,664 allocation. See details	Health and Human Services, Department of	7/29/2010
EMORY UNIVERSITY	$13,750	Trans-NIH Recovery Act Research Support Shotgun Glycomics: Linking Glycan Structure and Function, 3R01GM085448-1 Shotgun Glycomics is a nanoscale approach that uses new bifunctional chemical derivatization to: 1) fluorescently tag all free glycans released from cell or tissue glycoconjugates; 2 This spending item is part of a $410,820 allocation. See details	National Institutes of Health	8/14/2009
MERLIN INTERNATIONAL, INC.	$12,703	Agiliance Training on site Risk vision course See details	Centers for Disease Control and Prevention	8/28/2010
EMORY UNIVERSITY	$12,500	Trans-NIH Recovery Act Research Support Chronic kidney disease (CKD) in children is a devastating illness. The prevalence of patients aged 0 ? 19 years with ESRD has grown 32% since 1990 and the mortality rate for children with ESRD receiving dialysis therapy is between 30 and 150 times that o This spending item is part of a $525,000 allocation. See details	National Institutes of Health	9/27/2009
EMORY UNIVERSITY	$10,560	Trans-NIH Recovery Act Research Support Cancers of the large intestine cause more deaths in the United States than those arising in any other organ but the lung. Despite tremendous progress, the factors that initiate and promote the progression of neoplasia in the colon are incompletely underst This spending item is part of a $349,844 allocation. See details	National Institutes of Health	5/21/2009
SWORD & SHIELD ENTERPRISE SECURITY, INC.	$9,542	Fluke Combo Single Link TAP See details	Centers for Disease Control and Prevention	8/26/2010
ARETE GOVERNMENT SOLUTIONS, LLC	$6,492	he Centers for Disease Control have a Centers-wide requirement for transportable USB storage devices which will significantly increase CDC personnel productivity. CDC personnel will be able to access data stored on these devices wherever they may be. Gove This spending item is part of a $328,376 allocation. See details	Centers for Disease Control and Prevention	9/30/2010
ARETE GOVERNMENT SOLUTIONS, LLC	$2,374	he Centers for Disease Control have a Centers-wide requirement for transportable USB storage devices which will significantly increase CDC personnel productivity. CDC personnel will be able to access data stored on these devices wherever they may be. Gove This spending item is part of a $126,911 allocation. See details	Centers for Disease Control and Prevention	9/29/2010
EMORY UNIVERSITY	$0	Trans-NIH Recovery Act Research Support These are supplemental funds under the American Recovery and Reinvestment Act of 2009 (ARRA) for 1 UO1 AI077821-02. The parent grant supports investigators participating in the Clinical Trials in Organ Transplantation in Children (CTOTC)-02 multicenter tr This spending item is part of a $78,517 allocation. See details	National Institutes of Health	9/13/2010

Recovery Tracker

DeKalb County, Ga., funds by Health and Human Services, Department of